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ABSTRACT OF THE DISSERTATION  
 
Understanding Single-Molecule Protein Dynamics via Electronic Circuit 
 
By 
 
Mariam Iftikhar 
 
Doctor of Philosophy in Chemistry 
 
 University of California, Irvine, 2017 
 
Professor Gregory A. Weiss, Chair 
 
Molecular motions of proteins and their flexibility induce conformational states 
required for enzyme catalysis, signal transduction, and protein-protein interactions. 
However, the mechanisms for protein transitions between conformational states are 
often poorly understood, especially in the millisecond to microsecond range where 
conventional optical techniques and computational modeling are most limited. To 
investigate the microsecond dynamics of enzymes, single-walled carbon nanotube – 
field-effect transistors (SWCNT-FETs) were used as single-molecule biosensors. The 
SWCNT-FETs have sufficient sensitivity and bandwidth to monitor the conformational 
motions and processivity of an individual cAMP-dependent protein kinase A (PKA) 
molecule. Protein attachment is accomplished by functionalizing a SWCNT-FET device 
with a single protein and measuring the conductance versus time through the device as 
it is submerged in an electrolyte solution. PKA-functionalized nanocircuits elucidated the 
time PKA spent traveling between three different conformational motions upon binding 
of its two substrates.  
To generalize this approach for the study of a wide variety of proteins at the 
single-molecule level, this dissertation investigates the bioconjugation process to 
xv 
 
determine and isolate the key parameters required for functionalizing a SWCNT with a 
single protein. Further analysis into the parameters implicated in the thiol-maleimide 
bioconjugation step of the SWCNT-FET device fabrication proved an exhausting effort. 
We developed improved linker molecules, anthracene maleimide, for attachment of 
three different proteins to the SWCNT and a new derivative of maleimide providing a 
solution to overcome side reactions associated with the reducing agent, tris(2-
carboxyethyl)phosphine (TCEP). Protein purity and presence of detergent proved to 
play key roles in preventing nanocircuit surface fouling. An alternative bioconjugation 
method, utilizing an azide-functionalized hen egg-white lysozyme (HEWL) to tether the 
enzyme to the SWCNT through an alkyne linker molecule was developed. The work 
described here explores the current SWCNT attachment method as well as a new 
strategy to apply SWCNT-FET devices to study novel proteins. The results demonstrate 
SWCNT-FET as a sensitive technique for studying conformational dynamics of 
biological molecules in the microsecond range.  
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Chapter 1: Measurements and Models of Enzymes: Traveling between 
States 
1.1 Abstract:  
The movement of enzymes between conformations enables enzymatic functions 
from allostery to catalysis.1-3 Through understanding these molecular transitions, we can 
gain insight into the mechanisms and evolution of enzyme function. Conformational 
transitions have been studied by molecular modeling,4,5 ensemble,6,7 and single 
molecule measurements,8-13 which are surveyed here. A confluence of longer 
timescales in molecular modeling and shorter time domain measurements by various 
ensemble experimental techniques opens new windows into the events at the heart of 
biochemistry. Ensemble measurements with many molecules in solution allow studies of 
the broad functionality of enzymes though they typically do not allow detailed insight into 
the movements of individual molecules.14 In contrast, single molecule measurements 
offer direct observations of an individual enzyme molecule as it moves between states. 
Such studies uncover insights into the basis for evolution of enzyme function correlated 
to protein motion. A key step in these experiments is bioconjugation of the biomolecules 
to the surfaces or platform of devices. Several bioconjugation strategies are discussed 
here. Understanding enzymes at the mechanistic level could allow development of 
variants with superior functionality or therapeutics tailored to block specific motions of 
disease-associated enzymes.  
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1.2 Importance of enzyme dynamics – interconversion between states 
 Enzymes play essential roles in almost all life processes, from accelerating 
various metabolic reactions to controlling signaling transduction. The regulatory and 
catalytic functions of enzymes require dynamic conformational changes of protein 
structure.15,16 The interplay between molecular motions and functions has been 
extensively studied and reveals a range of motion distances (Å to nm) and timescales 
(ps to s).16 In many cases, the exchange between different catalytically functional states 
for the enzymes occurs on a µs to ms timescale, which also coincides with typical 
timescales of protein folding.1 The ability to resolve in real-time the dynamic and kinetic 
behavior of proteins at relevant timescales provides an opportunity to understand the 
complex behavior of proteins as they perform their processes. New methodological 
approaches, as discussed below, focus on structural fluctuations and their 
consequences to protein function to the static three-dimensional structures determined 
by structural biology.  
Additionally, structural fluctuations can uncover static and dynamic changes to the 
reaction rates of the enzyme. Static disorder compares individual molecules’ reaction 
rates with each other whereas dynamic disorder is the fluctuation of the reaction rate 
over time for a single molecule. If the energy barrier between conformational 
fluctuations is low enough to allow the interconversion between states at a rate faster 
than the reaction rate, then dynamic disorder occurs.17 The static disorder and dynamic 
disorder of reaction rates are essentially indistinguishable in ensemble-averaged 
experiments.17 At the single molecule level, dynamic disorder leads to stretched 
distributions of waiting times due to the fluctuations in the rate constants within an 
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individual protein.18 This widespread distribution of rate constants within a single 
molecule provides information on the accessible conformations. Minimal dynamic 
disorder can be detected in some biological processes by the experimental techniques 
that distinguish the number of rate-limiting processes. Some biological processes 
require precise control in order to repeatedly and effectively perform a function on a 
specific substrate. For example, single molecule measurements of T4 lysozyme (T4L or 
lysozyme) revealed multiple rate-limiting steps in the presence of its substrate 
peptidoglycan.19 Other enzymes such as cAMP-dependent protein kinase A (PKA) can 
undergo rapid conformational changes to effectively bind and phosphorylate a diverse 
number of target substrates.20 The fast fluctuations between different states lead to 
higher dynamic disorder masking many of the minor rate-limiting steps. Thus, T4L 
moves slower than PKA perhaps as a consequence of the time T4L takes to process 
one specific substrate.  
Furthermore, the effects of conformational motion of enzymes on their catalysis 
remains a controversial topic in enzymology.21 Views on catalysis describe the transition 
from the substrate-bound state, ES, through the transition state to the product bound 
state, EP. Two predominant theories dominate the discussion. The first theory states 
that non-equilibrium effects due to conformational motion and dynamics affect the 
reaction rate, i.e., provide directionality along the reaction coordinate to minimize any 
barrier re-crossings from product to reactants.22-24 The other theory suggests that 
catalysis is due to the enzyme providing an electrostatically pre-organized environment 
that lowers the barrier to the transition state rather than solely due to non-equilibrium 
protein dynamics.21,25 Other theories predict that enzyme catalysis is due to steric strain, 
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near-attack conformations, entropic effects, desolvation, and formation and separation 
of low-barrier hydrogen bonds.21 Enzyme-based catalysis may indeed be driven by one 
or more of these effects.  
The recognition step for ligand binding leading from the unbound state of the 
enzyme, E + S, to the substrate-bound state, ES remains controversial too.26 The two 
predominant mechanisms in which enzymes recognize their cognate ligands are 
through conformational selection27,28 or by induced fit.29 The conformational selection 
model describes a highly flexible enzyme that continually samples its conformational 
space for a suitable conformation to bind its ligands, i.e., large-scale conformational 
changes occur before ligand binding. The induced fit model differs in that the large-
scale conformational changes proceed after ligand binding. Enzymes may use these 
mechanisms or a combination of these mechanisms to bind their cognate ligands.30-32 
Sophisticated biophysical methods are needed to elucidate the mechanisms of 
various biological processes. Emerging technologies provide an understanding of 
protein variability, time-dependent variability (disorder), and innate mechanistic behavior 
of an enzyme during individual binding, unbinding, or catalytic events. In addition to 
spatial arrangement, dynamic fluctuations have been identified as a driving force for 
many types of molecular interactions. Moreover, single molecule studies of a range of 
biological systems can offer the opportunity to resolve many of these controversies.  
1.3 Techniques that measure travel time between enzymatic states  
Accurate characterization of dynamic travel time between enzymatic states is 
important for understanding the relationship between conformational dynamics and 
protein function. Protein dynamics are characterized not only by the timescale of the 
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fluctuations (a kinetic component) but also by the amplitude and the directionality of the 
fluctuations (a structural component). Consequently, the energy landscape representing 
a protein, which has many atoms, is highly multidimensional. Thus, a variety of 
techniques are required to fully investigate many of the dynamic timescales that 
enzymes traverse (Figure 1-1).   
 
Figure 1-1. Timescale of dynamic processes in proteins and the experimental 
methods that can resolve fluctuations on each timescale 
 
First, nuclear magnetic resonance (NMR) methods provide insights into localized 
sub-nanosecond dynamics of proteins, such as loop motions and bond vibrations. This 
technique delivers results on the timescale of protein chemical transitions, together with 
atomic resolution. Dynamic information can be deduced from the relaxation of nuclei 
after excitation using a variety of NMR experiments. This technique can span 
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timescales from ps to s and assess distances amongst several types of nucleus (1H, 2H, 
13C and 15N) site specifically. Importantly, the dynamics can be followed in solution 
under steady-state conditions. This is in contrast to most other spectroscopic methods, 
which require some perturbation to measure kinetics. NMR experiments have 
traditionally been limited to small, soluble proteins. However, modern spectrometer 
technology (such as high magnetic fields and cryoprobes) and new NMR pulse 
sequences have pushed the size limit upward, making it possible to study proteins of up 
to 100 kDa33 and even up to the size of the ribosome,34 depending on the system and 
question investigated. 
The NMR timescale for conformational exchange is defined by its rate relative to 
the chemical-shift timescale. For a slow interconversion rate, the sub-states are 
observed as distinct peaks in the spectrum, allowing direct structural characterization. 
By contrast, at intermediate and fast exchange rates, a single population-averaged 
signal is obtained from NMR analysis. Microsecond to millisecond dynamics can cause 
additional line broadening of this signal. For example, the dynamics of individual 
microscopic steps (i.e. binding and dissociation) of the catalytic cycle of cyclophilin A 
(CYPA) were dissected through NMR experiments.35-37 15N-labeled CYPA was 
monitored with an NMR spin relaxation experiment that measured the chemical 
exchange time constants. Characteristic motions detected during catalysis were already 
present in the free enzyme with frequencies similar to the turnover number. Thus, such 
dynamics are an intrinsic property of the enzyme that is harvested during catalytic 
turnover. Furthermore, situations exist in which contributions from dynamics at different 
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timescales overlap. Typically, in these cases only the upper or lower limits of the time-
scale inherent to the motions can be defined. 
To corroborate and provide further insight into NMR experiments, computational 
methods can describe protein dynamics from the precise position of each atom to 
include temporal resolution for an entire protein molecule.  Molecular dynamics (MD) 
simulations provide correlations between motions that can be disentangled, a 
phenomenon that is obscured in experiments at the ensemble level. Most importantly, 
although experiments can determine what is moving and how fast, MD simulations can 
answer why molecules move, because the underlying forces, corresponding energies, 
and electronic and charge distributions are included in the simulation.  
For example, mixed quantum/classical MD simulations studying the motions of 
three different dihydrofolate reductase (DHFR) complexes resulted in the 
characterization of a network of coupled catalysis-promoting motions that extend 
throughout the protein.38 These results were obtained from a series of equilibrium 
simulations that allowed sufficient sampling of the entire reaction coordinate. Previously, 
crystal structures and NMR experiments of these DHFR complexes provided insights 
into the backbone dynamics of the protein. However, MD simulations revealed dynamic 
motions throughout the protein spanning ps to ns timescales. The resultant predictions 
inspire new experiments, and contribute essential insights into the combined effort to 
solve the puzzle of how proteins work. 
Additionally, fluorescence techniques, such as Förster Resonance Energy 
Transfer (FRET), allow direct observation of molecular movements on the timescale of 
milliseconds to seconds. FRET experiments monitor energy transfer from a donor to 
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acceptor fluorophore attached to the biomolecule of interest. For example, researchers 
study calmodulin binding to neuronal NO synthase reductase domain using FRET 
between donor Cyanine 3 and acceptor Cyanine 5 dye molecules. These studies reveal 
a physical means for calmodulin to alter and restrict the conformational states and 
lifetimes of the NO synthase reductase.39 However, FRET experiments are restricted by 
photo-bleaching of fluorophores preventing the ability to record shorter faster events 
over longer time periods. Some doubts have been raised about the effects of the 
attached fluorophore on the dynamic movements of the enzyme.40,41 An attached 
molecule can slow down the reaction rates of the enzyme and increase dynamic 
disorder, thus obscuring rate-limiting steps.42  
Lastly, high-speed atomic force microscopy (HS-AFM) offers imaging acquisition 
on the timescale of milliseconds to seconds. This technique involves mechanical 
tapping of a small cantilever, on the scale of biomolecules, to physically image protein 
structure.43 HS-AFM can record a movie of the protein motion with an imaging speed of 
~33 frame/s providing temporal and spatial resolutions compatible with the dynamic 
analysis of biological samples. For example, a detailed real-time analysis of the protein 
F1-ATPase using HS-AFM revealed information about the propagation of conformational 
change throughout the β subunits. Each β subunit fluctuated between an open state 
and a retracted closed state. These results indicated that the three catalytic β subunits 
were operating cooperatively for sequential power stroking.43 HS-AFM is a powerful 
technique for observing such motor functions, although the proteins must be 
immobilized on a surface. However, this method is still limited to observing dynamic 
motion on the millisecond scale due to the physical limitations of the HS-AFM tip. 
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Collectively, these conventional experimental techniques fall short in observing 
catalytically important movements in the microsecond range. In addition, conformational 
changes over this timescale are too long for current all-atom MD simulation and NMR 
methods. On the other hand, large-scale structural rearrangements that take ms to s to 
complete have been used observed using FRET and HS-AFM (Figure 1-1). For these 
reasons, mechanisms underlying conformational changes in the microsecond range 
remain poorly understood. 
1.4 SWCNT-FET devices can study microsecond conformational changes 
The advent of one-dimensional electronic systems based on carbon 
nanotubes44,45 and silicon nanowires46 laid the foundation for the development of 
nanoelectronic (bio)chemical sensors. This approach can overcome the intrinsic 
limitations of fluorescence-based measurements, including attachment of a large 
fluorophore to the protein and photobleaching. By harnessing the low-dimensional 
electronic properties of these systems, the initial sensors based on these materials 
achieved label-free detection of specific analytes with high sensitivity.47-49 Researchers 
have extended the biosensor technology to the development of sensors using new 
materials such as graphene50,51 and understanding the mechanism underlying the 
sensitivity.52-55  
Electronic techniques based on single-walled carbon nanotube (SWCNT) field-
effect transistors (FETs)19,56,57 and nanopores58 have been developed with single-
molecule sensitivity. This integration of electronics with biosensors allows for label-free 
measurements with microsecond resolution, and durations that can span hours. 
Devices employing SWCNT-FETs are generalizable as their sensitivity, bandwidth, and 
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device architecture provides an opportunity to observe a range of chemical and 
biological systems. 
The sensing mechanism behind SWCNT-FETs arises through a Schottky barrier 
effect, i.e., modulation of the work function at the metal contacting the SWCNT, or an 
electrostatic gating effect.52 When the contact is passivated to prevent any adsorption 
onto it, the dominant mechanism of measurement is the electrostatic gating effect. This 
effect is caused by a change in the electrostatic environment due to adsorption or 
binding to the SWCNT. This principle was first applied in a molecular SWCNT sensor 
for the detection of NO2 and NH3 gas.
59 Later, a SWCNT-FET based glucose biosensor 
was developed using a single SWCNT coated with the redox enzyme glucose oxidase. 
The conductance of the enzyme-coated SWCNT increased in the presence of glucose, 
the substrate of glucose oxidase. These results suggested that SWCNTs could be used 
to monitor enzyme kinetics at a single-molecule level.59 This electronic, rather than 
optical, transduction allows monitoring of the dynamic interactions of individual enzyme 
molecules over long time periods. It provides real-time measurements with the potential 
of gaining information about enzyme reaction rates, intermediate states, and protein 
unfolding processes.  
1.5 Bioconjugation strategies for device fabrication 
Moreover, experiments resolved single-molecule kinetics with SWCNT-FETs 
using point-functionalized carbon nanotubes to covalently bind molecules at the defect 
or scattered electron site.56,57,59 For example, a single carboxylate group can be 
electrochemically introduced into the SWCNT sidewall and used to observe 
attachments and detachments of a carbodiimide hydrochloride.56 Using the same 
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functionalization technique, Sorgenfrei et. al. attached a single-stranded probe DNA and 
monitored DNA-hybridization kinetics in the presence of a complimentary DNA target.57 
While the introduction and modification of defects in SWCNTs allows for high sensitivity, 
it suffers from irreproducibility as the introduction of a defect can lead to the SWCNT 
becoming irreversibly insulating. To overcome these challenges, non-covalent 
modifications of the SWCNT were pursued to attain single molecule sensitivity.19,60  
Choi et al., for example, accomplished a single-molecule transduction using a 
pyrene-maleimide linker to tether a single lysozyme molecule to a SWCNT-FET.19 This 
non-covalent attachment relied on the π-π interaction between pyrene and the 
nanotube surface, providing a reliable method for functionalizing carbon nanotubes.61 
Unlike point-functionalization, this conjugation strategy had a high device fabrication 
yield, and did not introduce defects. The underlying signal transduction was driven by 
an electrostatic mechanism in which the motions of charged residues near the SWCNT 
sidewall change local electrostatic potential and modulate the source-drain current.62 In 
these experiments, a single T4L molecule was monitored at the microsecond timescale. 
Lysozyme orthologs have been studied for over a century, yet the nanocircuit devices 
unveiled new information about T4 lysozyme’s activities and dynamics, including its 
processivity and potential ability to transit peptide cross-links.19,60 This approach was 
further generalized to study molecular motions of two other enzymes, DNA polymerase 
I63 and PKA64 (discussed in Chapter 2). 
While the non-covalent functionalization of SWCNT is preferred, the thiol-
maleimide bioconjugation reaction has several limitations (discussed in Chapter 3) and 
alternative bioorthogonal reactions are needed (discussed in Chapter 4). Historically, 
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protein conjugation reactions involve the modification of lysine, cysteine, or nucleophilic 
tyrosine side chains with electrophilic agents such as N-hydroxysuccimide esters, 
maleimides, or an aryl diazonium salt, respectively.65-67 However, these conjugation 
strategies generally lead to heterogeneous mixtures of protein conjugates and 
attachment sites. The introduction of chemically orthogonal functional groups into 
proteins, on the other hand, has allowed for precise control of the conjugation site and 
stoichiometry.68  
Protein modification methods have been important in the biotechnology industry. 
Specifically, chemical tags69 and semi-synthetic methods such as expressed protein 
ligation (EPL)70 are viable techniques for protein modification. For example, chemically 
tagging PKA with a small tetracysteine motif allowed for site-specific chelation of a 
fluorescent biarsenical ligand and further demonstrated nuclear translocation of PKA 
during cAMP signaling.71 EPL was used to chemoselectively add a phosphotyrosine 
peptide to the C-terminus of Src kinase, which showed increased catalytic activity 
compared to non-phosphorylated Src kinase.72 Overall, these methods provide powerful 
techniques for bioconjugation.  
Protein bioconjugates are now routinely employed as valuable therapeutic agents 
and diagnostic tools in fundamental research.73-75 For example, the bioconjugate 
anibody-based therapeutic, Cimzia (UCB Pharma) a PEGylated humanized Fab’ 
fragment to treat Crohn’s disease, has been approved for commercialization.74 Strano et 
al developed a near IR fluorescent ATP sensor based on a SWCNT-luciferase complex, 
in which the luciferase was conjugated to phospholipids that wrapped the SWCNTs to 
modulate the fluorescence of SWCNTs based on ATP binding.76 These various 
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bioconjugation strategies and the improvements discussed in this dissertation address a 
bottleneck in nanocircuit device fabrication. These pitfalls and their solutions are 
inherent to all devices and materials reliant upon the conjugations employed here.  
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Chapter 2: Monitoring the Single-Molecule Dynamics of PKA by 
Functionalization of Single-Walled Carbon Nanotube Circuits 
 
2.1 Abstract 
Defects in protein kinase function are directly associated with a wide range of 
diseases. Protein kinases are among the most important targets for therapeutic 
intervention because they phosphorylate 30% of all cellular proteins and, therefore, 
regulate almost every cellular event. Determination of protein function using single 
molecule techniques has emerged as a landmark method for understanding enzyme 
dynamics. A single molecule of the catalytic domain of cAMP dependent protein kinase 
A (PKA) was attached to a SWCNT-FET device for monitoring dynamic protein motion. 
The kinetic rates governing ternary complex formation through the apo, intermediate 
and closed enzyme configurations were observed by recording a single PKA molecule 
over the course of ten minutes, allowing analysis of tens of thousands of binding events. 
Furthermore, the varying substrate-protein kinetic rates for bound and unbound states 
of PKA were observed. This technique will aid in the understanding of how kinases 
function and will clarify the interplay between conformational motion and catalytic 
activity.  
Furthermore, PKA is a dynamic protein with many known binding partners. For 
example, the catalytic activity of PKA is inhibited by caveolin-1. In collaboration with 
another Weiss laboratory member (Josh Smith), the mechanism of inhibition of PKA 
was studied with a soluble caveolin-1 variant (cavsol).  
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2.2 Introduction  
 The human genome includes an estimated 518 protein kinases (constituting 2% 
of the entire mammalian genome), which phosphorylate about a third of all proteins in 
the cell.2  Protein kinases play critical roles in almost every cellular and metabolic 
process including contractile activity, growth, and apoptosis. Modulation of their activity 
is crucial, because their malfunction leads to a variety of diseases, such as cancer, 
Alzheimer's, and Parkinson's disease.3-7 Thus, protein kinases' activation and inhibition 
are tightly regulated through phosphorylation (either autophosphorylation or by other 
kinases), by binding partners such as small molecules, or through control over their 
location within the cell.3,4  
 One class of kinases is regulated by a small molecule secondary messenger 
cyclic adenosine monophosphate (cAMP). For example, PKA exists as an inactive 
complex of two catalytic (C) subunits and a cAMP binding regulatory (R) subunit dimer.8 
Four cAMP molecules bind to the R-subunits of PKA, and facilitate the dissociation and 
activation of the C-subunits. This mechanism of activation is also relatively simple 
compared to other protein kinases.8  
 All protein kinases regulate their target proteins using the same chemical 
reaction in eukaryotic cells: phosphorylation of a recipient protein by transferring one of 
the phosphate groups of adenosine triphosphate (ATP) to a hydroxyl moiety on a 
protein substrate. In vivo, PKA functions as a serine/threonine kinase. PKA (40.8 kDa) 
is one of the simplest and smallest protein kinases, thus providing a model kinase for 
study of this class of proteins.3-9 Furthermore, the general secondary and tertiary 
structure of the catalytic core region is conserved throughout all protein kinases, unlike 
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the R-subunit.10 Therefore, the C-subunit of PKA (from here on referred to as PKA) 
serves as a model system for viewing more complex protein kinases.11-13 Through many 
cellular processes, PKA undergoes multiple states of activation and inactivation which 
are associated with substantial conformational changes to the kinase core.3-8  
 PKA has evolved sensitivity for binding a variety of substrates, polypeptide 
inhibitors, and scaffold proteins through recognition of arginine residues on binding 
partners.11 Three different conformational states: apo, intermediate, and closed, have 
been observed from structures obtained from X-ray crystallography and NMR of the C-
subunit alone or in complexes with various ligands.5,14 The apo state is the open 
conformation of PKA and the two distinct intermediate states are either ATP-bound PKA 
or substrate-bound PKA. When both ATP and the substrate are bound, PKA can close, 
and catalysis occurs.14 Despite this information, the crystal structures of PKA provide a 
static view of various conformational states. Understanding the dynamic features of 
catalysis such as kinetic rates associated with structural changes in real-time remains a 
challenge.3 
 In an ensemble experiment carried out by the Taylor laboratory, kinetic 
measurements of PKA were obtained to determine enzyme-ligand interactions in such 
dynamic processes as induced-fit substrate binding and conformation-linked product 
release.15 Due to the averaging effects of these bulk experiments, the individual PKA 
kinetic rates of catalysis were masked by many molecules in solution. Single-molecule 
experiments, on the other hand, allow the monitoring of the conformational changes to 
determine the catalytic rates of one enzyme.  
20 
 
 The most common single-molecule techniques, including fluorescence 
resonance energy transfer (FRET) and other optical experiments, can characterize the 
conformational dynamics and kinetics of individual molecules. FRET experiments 
employ the use of fluorophores with overlapping excitation and emission wavelengths, 
which can be positioned at specific locations on a protein and used to report molecular 
dynamics.16 This method, however, is limited by fluorophore bleaching, which prevents 
long-duration measurements of the same individual molecule. Single-molecule protein 
conformational fluctuations span an extremely broad range of timescales. Thus, 
techniques allowing longer observations could provide more realistic information about 
enzyme processes.17-20  
 To overcome limitations associated with fluorescence techniques, the Weiss and 
Collins laboratories developed a novel approach for monitoring individual enzyme 
molecules. Each examined molecule was attached to SWCNT-FETs through a bi-
functional pyrene-maleimide linker molecule, allowing attachment through pi-stacking 
interactions. Furthermore, a single cysteine engineered into the enzyme allowed for 
bioconjugation through a 1, 4 – Michael addition reaction (Figure 2-1).18,19 Once the 
molecule is attached to the SWCNT, small fluctuations in conductance through the 
Figure 2-1. Pyrene-maleimide linker attachment chemistry. The thiol group 
attacks the unsaturated imide group forming a stable carbon-sulfur bond. 
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SWCNT-FET can be detected. The substrate driven conformational motions of T4 
lysozyme induced such changes in electronic signals in the underlying transistor.18,19 
The two levels of current observed in the electronic data were associated with the open 
and closed conformational states of lysozyme. Lysozyme orthologs have been studied 
for over a century, yet the nanocircuit devices unveiled new information about T4 
lysozyme’s activities and dynamics, including its processivity and potential ability to 
transit peptide cross-links.18,19 Thus, this single-molecule technique has proven to be an 
effective way to study enzyme dynamics and kinetics. 
 In this chapter, this technique was expanded upon to study a single cysteine 
variant of PKA (T32C). Measurements were made in the presence of buffer, ATP, 
substrate, and ATP with substrate. The dynamic interconversion rates between the 
three conformational states of PKA were determined.20 The structural changes 
necessary for ATP binding take longer time periods than for the enzyme than substrate 
binding. This technique will elucidate the correlation between conformational motion and 
catalytic reactivity.  
 PKA is a dynamic protein involved in many cellular signaling cascades. Often 
proteins involved in the cascades tend to congregate in membrane microdomains 
termed caveolae. Caveolin-1 is the membrane protein in these caveolae that functions 
as a scaffold protein to organize binding complexes. Thus, caveolin-1 is a protein that 
interacts with and tends to inhibit many different binding partners, including PKA.21 In 
addition to studying PKA at the single-molecule level, experiments with PKA and 
caveolin-1, were performed in ensemble binding studies. Using techniques such as 
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S65C 
T32C 
S139C 
N113C 
L82C 
Figure 2-2. Surface map of PKA. a) Front view of the 
enzyme with three positions targeted with cysteine 
mutations (S65C, L82C, S139C). b) Rotated 180⁰ , 
this alternative view of the enzyme show two 
additional cysteine mutations (T32C and N113C). 
a b 
Overlap Extension PCR 
1     2      3     4     5     6      7 
Extension PCR 
1: DNA ladder 
2: L82 PCR a 
3: N113 PCR a 
4: S139 PCR a 
5: L82 PCR b 
6: N113 PCR b 
7: S139 PCR b 
1     2     3     4     5     
1: DNA ladder 
2: T32C 
3: S65 
3: L82 
4: N113 
5: S139 
Overlap PCR 
Figure 2-3. Overlap 
extension PCR of 
PKA variants. 
Depicted in lanes 1: 
GeneRuler 1 kb DNA 
ladder, ready-to-use 
(Fermentas).  2: L82 
PCR a 3: N113 PCR 
a 4: S139 PCR a 5: 
L82 PCR b 6: N113 
PCR b 7: S139 PCR 
b. PCR products are 
all at the correct base 
pair length (between 
600 bp and 750 bp).  
Enzyme-Linked Immunosorbent Assays (ELISA) and Isothermal Calorimetry (ITC), the 
mechanism through which cavsol interacts with PKA was described here.  
2.3 Engineering a single cysteine variant of PKA  
Since a single 
cysteine is required for 
bioconjugation, five surface-
exposed single 
cysteine variants of PKA 
(Figure 2-2) were engineered 
using site-directed mutagenesis by overlap extension 
polymerase chain reaction (PCR). In this technique, a 
portion of the gene is amplified with the mutagenic primers, 
then a second round of PCR amplifies the variant gene using 
the previous PCR products as primers to amplify the vector 
fragment.22,23 The resulting full-length PCR products were 
then sub-cloned into isolated pET vectors (Figure 2-3 and 2-
4). Mutation sites were placed in flexible regions directly 
between areas of secondary structure to limit the impact the 
modification could have on protein stability and to ensure 
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detection by the nanodevice when 
small conformational changes take 
place. These mutations were close 
to charged residues, since moving 
charges can contribute to the 
electrons flowing through the carbon 
nanotube and in turn affect the 
conductance signal.24  
The PKA variants were over-
expressed in BL21 (DE3) cells. The 
T32C PKA variant expressed most 
efficiently overall, and was used for 
further study (Figure 2-5). T32C PKA 
has an isoelectric point (pI) of 8.4, 
imparting an overall positive charge. 
Thus, it was purified using strong cation 
exchange chromatography, which has a 
negatively charged resin (Figure 2-6). 
Subsequently, T32C PKA can be eluted 
from the column by changing the ionic 
strength of the buffer. For ≈99% 
homogeneity of T32C PKA variant, size-
1   2     3    4      5   
 
Figure 2-5. T32C PKA expression. This 
15% SDS-PAGE is an example of T32C 
PKA variant expression in BL21 (DE3) 
cells. The lane numbers indicate: 1) 
PageRuler Plus Prestained Protein Ladder 
(Fermentas), 2) Wild-type PKA used as a 
standard, 3) Whole cell lysate, 4) 
Supernatant where the box indicates the 
variant at the correct size of 40.8 kDa, and 
5) Pellet.  
 1    2      3    4     5     6     7        
Figure 2-4. Full length PCR for six samples 
of T32C PKA variant (Lanes 2-7). PCR 
products are at the correct base pair length 
(~1200 bp). In lane 1 is the GeneRuler 1 kb 
DNA Ladder, ready-to-use (Fermentas). 
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exclusion chromatography was used for further purification (Figure 2-7). An activity 
assay was performed to check the viability of the T32C PKA variant (Figure 2-8).25 In 
this assay, catalytically active PKA converts NADH to NAD+, which can be monitored 
via a decrease in absorbance at 340 nm. The variant was compared to a positive 
control, wild-type PKA at the same enzyme concentration and identical conditions 
(Figure 2-9). The 
absorbance at 340 nm for 
T32C PKA variant and wild-
type PKA (WT PKA) 
decreased yielding kcat 
equal to 1.619 and 1.742 
mA340/min, respectively. The 
kcat for the reaction with no 
enzyme is 0.095 mA340/min. 
From this data, it can be 
concluded that T32C PKA 
has activity comparable to 
WT PKA, allowing accurate 
comparison for single-
molecule studies.   
  
  
 
 1      2     3      4      5      6     7    8     9      10           
Figure 2-6. T32C PKA purification with strong 
cation exchange chromatography. This 15% SDS-
PAGE gel demonstrates ~85% homogeneity of 
T32C PKA after applying to P-11 cation exchange 
resin. Lane 1 is PageRuler Plus Prestained Protein 
Ladder (Fermentas) and lane 2 is wild-type PKA 
used as a standard. Lanes 3-10 are fractions 
collected from strong cation chromatography. The 
box indicates the fractions collected for further 
purification. 
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After expression 
and purification of T32C 
PKA, it was necessary to 
investigate optimal 
storage conditions for the 
protein. After large scale 
expression (12 L) of T32C  
PKA, ten different storage 
conditions were tested 
(Table 2-1). To ensure 
long-term storage (over 
Figure 2-7. Purification of the T32C PKA variant by size-
exclusion chromatography. This 15% SDS-PAGE 
provides an illustrative example of the purity of the 
expressed PKA variant. The arrow indicates the 
expected MW for the migration of T32C PKA (40.8 kDa). 
Lane 1 is the PageRuler Plus Prestained Protein Ladder 
(Fermentas).  
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Figure 2-8. PKA activity assay schematic. This schematic diagram demonstrates 
the indirect method for detection of active PKA. As Kemptide is phosphorylated 
by PKA, ADP is generated. ADP, in turn, is converted back to ATP when 
pyruvate kinase (PK) dephosphorylates phosphoenolpyruvate (PEP). Pyruvate 
is then converted to lactate by lactose dehydrogenase (LDH) using NADH. The 
disappearance of NADH is monitored via the decrease in absorbance at 340 
nm.  
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one month), conditions such as snap freezing with liquid nitrogen to prevent any crystal 
formation in the protein solution 
were compared to freezing at -80 
°C and -20 °C. Glycerol (10%) has 
also been described in preventing 
protein crystallization.26 Lastly, 
lyophilization was investigated as 
another alternative to preserve 
protein structure and function. PKA 
samples were stored in these 
conditions at the same 
concentration (1 µM) for one month 
and compared to a positive control 
of a newly purified PKA sample. 
These PKA storage samples were 
tested using the PKA activity assay. The decrease in rate over time corresponds to 
more active PKA. Overall, the best storage conditions proved to be freezing at -20 °C 
with 10% glycerol as well storage at 4 °C. Though lyophilization was the best storage 
condition for recovering active PKA, we were unable to get any bioconjugation to the 
SWCNTs after protein reconstitution. Thus, PKA samples were most often stored at 
either 4 °C or frozen at -20 °C with 10% glycerol for long term storage.  
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Figure 2-9. PKA activity assay with T32C 
and WT PKA. A negative control with no 
enzyme present under identical condition 
showed essentially no activity. (n = 3) 
Sample kcat (mA340/min) r
2
WT PKA 1.742 0.982
T32C PKA 1.619 0.981
No enzyme 0.095 0.756
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Figure 2-10. Schematic of a single core 
catalytic subunit of PKA (small lobe in 
cyan and large lobe in gray) attached to 
a carbon nanocircuit through a single 
cysteine (yellow). Two magnesium ions 
(orange) position ATP (blue) in the 
binding pocket. As PKA catalyzes the 
transfer of phosphate from ATP to its 
substrate, Kemptide (magenta), the 
protein undergoes a conformational 
change from the open (opaque, PDB: 
1J3H) to the closed conformation 
(transparent, PDB: 1ATP). 
Figure 2-11. Representative AFM 
image of a SWCNT device with a single 
protein attachment (arrow).  A single 
SWCNT was connected to Pd 
electrodes. Horizontal stripes at top and 
bottom show the extent of a passivating 
(poly(methylmethacrylate), (PMMA) 
layer that covers the distant electrode 
connections. Only 1 mm of the SWCNT 
sidewall, exposed by electron beam 
lithography of the PMMA, was in direct 
contact with the liquid solution when the 
device was submerged in buffer. 
2.4 Experimental Setup  
All PKA-functionalized devices 
used for this work were fabricated, 
characterized, and measured using 
previously described methods.18,19 To 
attach a single enzyme molecule to the 
nanodevice, T32C PKA was incubated 
with SWCNT-FETs that had been non-
covalently functionalized with pyrene-
maleimide linker molecules (Figure 2-10). 
PKA has two naturally occurring cysteines 
(C199 and C343), which are hidden in the 
hydrophobic core.8 During functionalization, 
a solution of 2 mM ATP and 2 mM MgCl2 
was used to sterically block nonspecific 
interactions of the two cysteine side chains 
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in PKA as described in a previous report.13 Atomic force microscopy (AFM), a very high 
resolution imaging technique that uses a mechanical probe to magnify surface features 
and produce 3-D images of the surface was used to detect PKA successfully 
bioconjugated to the nanodevice (Figure 2-11).   
2.5 Control Electronic Measurements of PKA 
The mechanism through which the SWCNT is sensitive to protein conformational 
motion was determined previously. The charged residues near the conjugation site 
move as the protein is changing conformations, thus affecting the SWCNT near them.24 
Figure 2-12 depicts the geometry of a SWCNT device and its PKA attachment based on 
the position of the T32C site. Charged residues in motion near to T32 during enzyme 
opening and closing could allow SWCNT device to respond to conformational changes 
during enzymatic catalysis. 
Figure 2-12. A schematic diagram of the PKA-SWCNT interface, showing X-
ray crystal structures of PKA in its closed (opaque) and open (transparent) 
conformations (PDB: 1ATP and 1J3H, respectively). The C32 attachment to 
the pyrene-maleimide linker molecule provides a fixed reference point.  In the 
vicinity of C32, residues 28 and 31 have charged side chains that move 
appreciably from the open configuration (light gray) to the closed conformation 
(black).  The pyrene and SWCNT are independently free to rotate around the 
C32 site, but this illustration depicts an energetically likely orientation. 
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After bioconjugation, devices were stored and then measured in a buffered 
aqueous solution (100 mM MOPs, 9 mM MgCl2, 100 µM TCEP, pH 7.2). Measurements 
were performed by applying a fixed, 100 mV source-drain bias along the SWCNT 
conductor while continuously monitoring the source-drain current, Isd(t). The attached 
PKA then interacted with its co-factor ATP or its peptide substrate Kemptide27 added 
singly or as mixtures to the solution. Isd(t) recordings extended continuously for at least 
300 s in each experiment; this Isd(t) measurement was digitized at 100 kHz and stored 
for subsequent analysis. To assist stability during long duration measurements, the 
electrolyte potential was 
controlled at -300 mV 
relative to the drain 
electrode using a Pt 
pseudo-reference 
electrode.  
Control 
measurements were 
conducted using a device 
from the same chip that 
had a successful protein 
attachment. The control 
and functionalized devices 
simultaneously underwent 
the protein attachment 
Figure 2-13. Control measurements of a pyrene-
maleimide coated SWCNT device, with no attached PKA.  
In the presence of ATP and/or Kemptide, I(t) through the 
device shows no fluctuations except for the characteristic 
1/f noise found in all SWCNT electronic devices.   
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Figure 2-14. Representative ΔI
sd 
(t) signals and signal 
distribution histograms for a PKA-labeled SWCNT device.  
a) Unfiltered, raw data as measured in buffer, showing the 
absolute value of I
sd 
(t).  b-d) ΔI
sd 
(t) relative to the 
baseline current, as measured in the presence of b) 2 mM 
ATP, c) 100 μM Kemptide, and d) both ATP and Kemptide.   
c 
d 
b 
a 
protocol, but the control device failed to yield an attachment. This device was then 
electrically measured in the buffered aqueous solution (pH 7.2), buffered aqueous 
solution (2 mM ATP), buffered aqueous solution (100 μM Kemptide), and buffered 
aqueous solution (2 mM ATP, 100 μM Kemptide).  As shown in Figure 2-13, no 
processive fluctuations from the baseline were observed. Thus, the signal measured in 
the presence of these substrates is due to presence of functional protein.  
2.6 Electronic Measurements of PKA Binary and Ternary Complexes 
Electronic measurements were recorded in a buffered saline solution alone and 
containing ATP, 
Kemptide, or both ATP 
and Kemptide (Figure 2-
14). Kemptide is a 
seven amino acid 
synthetic peptide 
(LRRASLG) derived 
from the sequence 
necessary for PKA 
recognition of the 
phosphorylation site, 
and presents as an 
effective PKA 
substrate.25 
Measurements were 
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performed by applying a fixed, 100 mV source- drain bias along the SWCNT conductor 
while continuously monitoring the source-drain current (Isd(t)). Control experiments 
measured in only buffer showed Isd(t) fluctuated about a mean baseline current (Figure 
2-14a) dictated by the noise of the carbon nanocircuit. The baseline current was 
subtracted from the signals obtained from experiments containing ATP, Kemptide, or 
both ATP and Kemptide. The electrical signals can be explained by an electrostatic 
transduction mechanism previously demonstrated using SWCNT devices and single T4 
lysoyzme molecules.18 
Data measured in the presence of one ligand induced two level current 
fluctuations below the baseline currents. When ATP or Kemptide binds to PKA, a binary 
complex is formed. In the presence of 2 mM ATP, there is one Isd(t) level at baseline 
current and another exhibited current fluctuations, ΔI, of -8 nA (Figure 2-14b). Similar 
excursions were observed when PKA was measured in a 100 µM solution of Kemptide, 
including one baseline current level and a ΔI of approximately -11 nA (Figure 2-14c). 
Differences in either amplitude or duration were investigated as possible metrics for 
distinguishing ATP-PKA excursions from Kemptide-PKA events in mixtures of the two 
reagents. However, neither approach proved practical. The amplitude distributions of 
binding to either ATP or Kemptide almost completely overlapped (Figure 2-15). 
Nevertheless, the mean duration of each binding event was distinguishably different. 
The mean time that PKA bound ATP by itself was 3.1 ms and for Kemptide-PKA the 
time was 1.8 ms. (Figure 2-15b) The current fluctuations below the baseline current 
were short-lived for ATP or Kemptide experiments, hence the smaller signal 
distributions.  
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In the absence of binding partners, the PKA apoenzyme adopts an open 
conformation in which the large lobe (residues 127 to 300) is 1.33 nm from the smaller 
lobe (residues 30 to 120, as measured with respect to the α -carbon of S53 and G186.28 
This stable, open conformation produces the baseline current observed in Figure 2-14a.  
Upon binding to either ATP or Kemptide, PKA moves into an intermediate conformation, 
in which the two lobes are separated by 1.18 nm or 1.07 nm, respectively. For either 
binding partner, the large lobe moves closer to the small one, which is attached to the 
SWCNT conductor.  Surface charges on the large lobe can act as an electrostatic gate 
3.1 ms  
0.8 ms 
125 s
-1
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Single Molecule   Ensemble 
Bound 
Unbound 
Association + 
Disassociation 
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Figure 2-15. Rates for the formation of the PKA binary complex with ATP and 
Kemptide, respectively. a) The zoomed in view shows the current fluctuations 
correlated to time the protein spent unbound with no substrate, and then 
subsequently the current fluctuations correlated to the time PKA was bound to 
either substrate. The protein is fluctuating between two conformational states. b) 
Table illustrating the rates determined by SWCNT-FETs and compared to 
ensemble measurements for both binary complexes of PKA. 
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on the SWCNT conductance; motions in concert with the active site by individual, 
charged amino acid side chains moving closer to the SWCNT attachment site are likely 
responsible for the signal transduction mechanism (Figure 2-12). 
Only in the presence of either ATP or Kemptide are two level current fluctuations 
observed, these disappear from the negative control measurements. Thus, these are 
caused by the formation of the binary complex (Figure 2-15a). According to previous 
research, the current fluctuations are caused by moving charged residues,24 which is 
indicative of a conformational change upon binding to ATP or Kemptide. By also 
analyzing the waiting times between each excursion, we extracted rates for one cycle of 
binding and unbinding by each ligand of 125 s-1 and 286 s-1 for ATP and Kemptide, 
respectively (Figure 2-15b). Thus, PKA cycles through binding and unbinding to 
Kemptide faster than to ATP. The results reported here confirm classic ensemble 
measurements showing PKA can bind independently to both Kemptide and ATP, but 
the exact order is largely random.29,30  
In the presence of both ATP and Kemptide, a third conformational state is 
observed. This is illustrated by three distinct levels of current fluctuations (Figure 2-14d). 
In addition to the baseline current and the current fluctuations of approximately -10 nA 
that correspond to the binary complex as described above, an additional third level of 
current fluctuations with -19 nA was observed. In a magnified view of the data for the 
PKA experiments with both ATP and Kemptide, the transitions between each 
conformational state were analyzed (Figure 2-16). These empirical observations were 
applied to examine the mechanism and catalytic activity of PKA, through detailed 
analysis of the electronic device signal from PKA-tethered nanocircuits. By comparing 
35 
 
the Isd(t) signal to PKA dynamics known from ensemble and FRET experiments,
16,27,31-33 
several conclusions can be made (e.g., PKA remains static in the absence of ligands). 
Moreover, PKA forms a stable ternary complex with two conformational states when 
both ATP and Kemptide are present.  
Each transient excursion ΔIsd(t) can be interpreted to result from one PKA 
binding event (Figure 2-16). This interpretation results in average waiting times and 
turnover rates that agree well with ensemble values.31,32 Control measurements further 
support this analysis by showing that in the absence of an attached PKA, pyrene-
maleimide functionalized SWCNTs exhibit none of the excursions shown with ligand 
binding (Figure 2-13). Furthermore, ΔIsd(t) fluctuations were reliably eliminated by 
rinsing ATP and/or Kemptide from the device, and restarted by reintroducing a binding 
partner. As an example of this, the data in Figure 2-14 is chronologically reversed: the 
baseline Isd(t) in Figure 2-14a was acquired after probing the device with ATP and 
Kemptide solutions; the results confirmed recovery of the baseline after testing. 
The effective catalytic turnover rate is described as the average time from the 
beginning of one closure to the next via the open configuration. In a single data set, 
Figure 2-16. The magnified 0.2 s view of data from Figure 2-14d indicates the 
high level of detail discernible in individual transitions.  In the discussion, the 
high, mid and low current states are assigned to the apo, the substrate- or co-
factor bound, and the catalytically functioning enzyme conformations, 
respectively. 
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20,000 such events were observed and a mean turnover rate of 110 s-1 was determined, 
which is similar to ensemble measurement values.3,16,34 The majority of turnovers (77%) 
followed a straightforward sequence of open-intermediate-closed-open conformations 
with an effective rate of 155 s-1, which was illustrated in a single discrete probability 
distribution indicating a single-step process (Figure 2-17). The enzyme accesses the 
closed conformation twice before opening at a slower rate of 110 s-1 for 13% of the 
turnovers.  
In addition, PKA cycles 
multiple times between the 
closed and intermediate states 
before finally opening with 
product release for 10% of the 
turnovers with an average rate 
of 40 s-1. Assuming that the 
complete release of the 
substrate and return to the apo 
conformation indicates 
successful phosphorylation, 
then 23% of turnovers can be 
considered as failed attempts 
to phosphorylate Kemptide, which remains bound while the enzyme repeatedly closes 
on it. Moreover, PKA has 77% probability of success during the first closure and only 
~50% probability of phosphorylation during each subsequent attempt (Figure 2-17). For 
Figure 2-17.  Probability of successful catalysis of 
phosphoryl transfer, as indicated by the return to 
the apo conformation.  Inset: Isd(t) trace shows an 
example of multiple transitions between the 
intermediate and closed conformations before 
finally re-opening. 
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some catalysis events, the enzyme cycled between the closed and intermediate states 
ten or more times, thus resulting in a relatively low probability of successful 
phosphorylation (Figure 2-17, inset). A minimal kinetic scheme consistent with this data 
is shown in Figure 2-18.  Furthermore, if the enzyme fails to catalyze the 
phosphorylation reaction each time it cycles between fully closed and the apo state, the 
turnover rates and efficiency could be even lower; the reported rates represent an upper 
bound on the catalytic efficiency of PKA.   
In a magnified view 
of the data for the PKA 
experiments with both ATP 
and Kemptide, the 
transitions between each 
conformational state were 
analyzed (Figure 2-16). It 
was shown that 73% of the 
time PKA starts in the open 
configuration and then 
transitions immediately to 
the closed ternary complex 
with no observable 
intermediate state. For the 
remaining 27% of the time, 
transitions to the intermediate configurations are observed, though ATP-PKA and 
E
E●ATP
E●ATP●Kemptide
E●Kemptide
E●ADP●phos-Kemptide
320 s -1
200 s -1
59
0 
s
-15
60
 s
-1
350 s -1
1
0
0
0
 s
-1
4
1
0
 s
-1
2
3
0
 s
-1
3
5
0
 s
-1
1000 s -1
4
1
0
 s
-1
2
3
0
 s
-1
Figure 2-18. A kinetic scheme for the PKA-catalyzed 
phosphorylation of Kemptide with rates measured by a 
single PKA functionalized SWNT device.   The 
thickness of the lines reflects the transition 
probabilities from Figure 2-1 with thicker lines 
indicating a higher probability. 
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Kemptide-PKA states are not distinguishable. Furthermore, the binding of ATP and 
Kemptide are known to be highly cooperative and occur at nearly simultaneous time-
scales. The enzyme must visit the intermediate bound state to form the ternary complex. 
However, the intermediate state cannot be detected 73% of the time using this 
nanodevice. The time resolution of this technique is 20 µs; hence, during this time the 
simultaneous binding of these two ligands could have occurred and not be resolved.  
 Single molecule measurements offer powerful tools to reveal enzyme variability 
and dynamic disorder, which are typically hidden during ensemble measurements. The 
timing of PKA binding to ATP and Kemptide measured here both exhibited the wide 
variability associated with the dynamic disorder of the enzyme. Examining continuous, 
45-second subsets of Isd(t) recordings for the two distinct intermediate binary 
a b 
Figure 2-19. Distribution of duration for enzyme-bound binary complexes. In 
a) and b), single-exponential line fits determining <t> are shown as solid lines. 
a) Distributions of the duration of the enzyme bound conformation for ATP or 
Kemptide (t
lo
). b) Distributions of the waiting times for ATP and Kemptide 
binding, with the shortest waiting times shown more clearly in the inset.(t
hi
).  
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complexes, the bound and unbound (waiting) times between each excursion were 
analyzed (Figure 2-19). Simple, single-exponential fits (solid lines in Figures 2-19a and 
b) determine τ values (unbinding and binding rates of either ATP or Kemptide) that 
represent the majority (95%) of events.20 Each binary complex had a high and a low 
current state characterized by durations, τhi and τlo, respectively. For ATP, the average 
unbinding and binding rate was determined to be 125 s-1 and for Kemptide the average 
rate was 286 s-1 (Figure 2-15b). The unbound time for ATP exhibits a much longer 
distribution tail meaning the enzyme takes more time to reach the ATP-PKA 
intermediate state. This can indicate that the enzyme has more difficulty in accessing 
the ATP-PKA conformation than the Kemptide-PKA state.  
2.7 Electrically-driven deposition of peptides onto SWCNT 
In order to further understand the recognition and regulation mechanism of PKA, 
it would be useful to consider the interaction PKA with various peptide inhibitors.  
Peptides, while biologically interesting, may cause additional complications when 
measured using SWNT sensors due to their potential to adsorb to the sidewall of the 
nanotube through hydrophobic and aromatic interactions.  This affinity however leads to 
additional possibilities in the selective adsorption and patterning of peptides on SWNTs.  
The particular peptide considered here is the protein kinase inhibitor (PKI).  PKI 
has the following sequence: Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-
Arg-Asn-Ala-Ile-His-Asp.35 Embedded within this sequence are positive and negatively 
charged residues; at pH 7.4, this peptide yields an overall net charge of + 2 q for PKI, 
but the net charge of the peptide fails to capture the inherent polarity within the 
sequence itself. The first half of the sequence carries an isolated negative charge due to 
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the aspartic acid while the second half carries four positive charges and a negative 
charge directly adjacent to one of the positive charged residues. This polarity within the 
sequence suggests that the molecule should be capable of being oriented in the 
presence of an external electric field.  
While the charge distribution within PKI suggests that the peptide could be 
electrically oriented and potentially driven to the SWCNT surface through the application 
of an external electric field, we hypothesize that the peptide must irreversibly adsorb to 
the sidewall in order to functionalize the SWCNT. Furthermore, this adsorption should 
be stable once the external electric field is no longer applied. For this to occur, we 
hypothesize the peptide has to interact with SWCNT in such a way that is independent 
of an applied electric field (e.g., aromatically or hydrophobically). In the case of PKI, 
there is a region encompassing the isolated negative charge that includes both 
hydrophobic and aromatic residues: Tyr-Ala-Asp-Phe-Ile-Ala. Of the twenty-one 
naturally occurring amino acids, three amino acids (phenylalanine, tyrosine, and 
tryptophan) are aromatic and eight amino acids (alanine, valine, isoleucine, leucine, 
methionine, phenylalanine, tyrosine, and tryptophan) are hydrophobic, and because of 
their aromaticity and hydrophobicity, these amino acids can adsorb to the SWCNT 
sidewall through a π-π or hydrophobic interaction, respectively.36 Of the seven 
hydrophobic residues in PKI, five of them surround the negatively-charged aspartic acid. 
Furthermore, of these five hydrophobic residues, two are also aromatic. Therefore, we 
predict that this negatively charged region should have a very high affinity to adsorb to 
sidewall of a SWCNT. 
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We predict that applying a negative potential to the liquid with respect to the 
SWCNT could drive PKI off the surface of SWCNT with the preferred orientation for 
adsorption. By applying a negative potential to the liquid, the negative region of the PKI 
can possibly orient itself in close proximity to the more positively charged nanotube. 
This was accomplished by applying a potential of -0.4 V to a 10 nM PKI solution 
(100mM MOPs, 9 mM MgCl2, 100 μM TCEP, pH 7.2) for 20 min.  The results for two 
devices can be seen in Figure 2-20. Figure 2-20a and b shows the devices before and 
after the electrically-driven deposition of PKI, respectively.  Even at low concentrations 
of PKI, a substantial peptide concentration deposited on the nanotube.  
To confirm 
that the adsorption 
of the PKI is 
initially electrically 
driven, it is 
necessary to show 
that minimal 
adsorption occurs 
in the absence of 
an applied electric 
field. Figure 2-21a 
and b shows the 
results before and after incubation for 30 min in 10 nM PKI solution. Evident from Figure 
2-21, even after 30 min incubation, no substantial deposition of PKI is seen on the 
Device 1 Device 2 
a 
b 
Figure 2-20. AFM images depicting PKI deposition on SWCNT. 
a) Before and b) after the electrically-driven deposition of PKI 
onto a SWNT using a 10 nM solution of PKI at -0.4V versus 
Pt(V
RE
) for 20 minutes. 
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nanotube as compared to Figure 2-20. From this it appears that the affinity imparted by 
the aromatic and hydrophobic residues within the PKI molecule is not sufficient to 
deposit onto the sidewall of the nanotube.  
In addition, Kemptide was tested for electro-deposition of peptides onto 
SWCNTs. Figure 2-21c shows the results of the attempt to electrically-drive Kemptide 
adsorption using a 100 µM solution of Kemptide (100 mM MOPs, 9 mM MgCl2, 100 μM 
TCEP, pH 7.2) at -0.4 V versus Pt(VREF). The results can be reasonably understood by 
examining Kemptide’s sequence in further detail. Kemptide carries an overall net charge 
a 
b 
c 
Device 1 Device 2 
Figure 2-21. AFM images depicting PKI and Kemptide interaction with 
SWCNTs. a) before, b) after a 30 minute incubation in 10 nM PKI solution, and 
after c) 20 minutes in a 100 µM Kemptide solution at -0.4V versus Pt(V
REF
).  
43 
 
of + 2 q due to the two arginine residues. This overall net charge is equivalent to that of 
PKI, but unlike PKI, Kemptide does not contain any negative charge residues that could 
impart an effective polarity to the sequence. Also, Kemptide does not contain any 
aromatic residues nor does it have comparable region of affinity to that of PKI where 
five of the six residues in a particular sub-sequence are hydrophobic.  
While this examination shows that some peptides can be electrically driven to 
adsorb onto SWCNTs, the exact mechanism behind the electrically driven deposition is 
still elusive. Since deposition of PKI is only observed in the presence of an externally 
applied electric field, this observation suggests that charged residues serve a critical 
role in rapidly transporting the peptide to the SWCNT surface. Furthermore, since the 
deposition is present after the external field is removed, this suggests that PKI has a 
high affinity for the nanotube. From the height of the depositions, it is clear that PKI can 
aggregate or self-assemble either electrostatically or hydrophobically. With further 
understanding and application of this phenomenon, it is plausible to produce peptide-
functionalized SWCNTs that could be used as sensors or as drug-delivery vehicles for 
therapeutic peptides. 
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2.8 PKA and caveolin-1 binding studies  
The mechanism of PKA inhibition with caveolin remains unknown. A soluble 
variant, cavsol, was a useful biophysical tool to study caveolin-1 inhibition in vitro.
1 Thus, 
PKA binding with cavsol was established using an ELISA (Figure 2-22a). Cavsol bound to 
PKA in a dose-
Figure 2-22. Protein-based ELISA investigating specific binding 
of PKA with cavsol. a) Dose-dependent binding between caveolin-
1 and PKA (purple). Cav
sol
 binds with moderate affinity and high 
specificity. b) Notably, cav
sol
 does not bind nonspecifically to off-
target proteins. Reported here.1  
a 
b 
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dependent manner. The soluble variant binds only to caveolin-1 binding partners 
(Figure 2-22b).  
 Furthermore, ITC was used to determine the thermodynamic parameters 
between PKA and cavsol (Figure 2-23).
1 The titrations results in sigmoidal binding curves 
Figure 2-23. Measuring binding between cav
sol
 and PKA by ITC. a) The upper 
panel depicts the calorimetric output from the cav
sol
 interaction with PKA. The 
lower panel depicts integration of the calorimetric output, where the x-axis 
indicates the molar ratio of PKA to cav
sol
. The least squares fit is shown by the 
solid line. b) ITC-derived thermodynamic binding parameters for interactions 
with cav
sol
. Error indicates standard error. Reported here.1 
a 
b 
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consistent with dose-dependent binding (Figure 2-23a). The fit for these curves follows 
a one-site binding model as determined through minimizing chi-squared for the fit to the 
curve. Analysis of the ITC data reveals that cavsol binds to PKA with modest affinity (Kd = 
0.670 µM). The stoichiometry of binding is one PKA molecule per three cavsol 
molecules. The binding even is exothermic and driven by enthalpic forces, rather than 
entropic considerations, as shown by the large negative ∆H values (Figure 2-23b).  
 Overall, we have successfully shown PKA binding with the soluble caveolin 
variant in the low micromolar range as expected for protein-protein interactions. This 
cavsol variant provides a biophysical tool to further investigate the mechanism of PKA 
inhibition.  
2.9 Conclusions  
 A single-cysteine (T32C) PKA variant was expressed and purified for single 
molecule studies with a SWCNT nanodevice. Three levels of ΔI are observed with PKA 
bound to the nanodevice in the presence of both ATP and Kemptide. These electronic 
transduction results clearly elucidate each step in the formation of the active, ternary 
complex, allowing individual measurements of multiple kinetic parameters involved in 
PKA processivity. Moreover, this data illustrates that attaining the ATP-PKA 
conformation is more difficult for the enzyme than Kemptide-PKA intermediate state. 
Currently, another variant with slower kinetic rates is being synthesized to elucidate the 
difference between the two intermediate states of ligand binding.  
 The catalytic activity of PKA is tightly regulated in both space and time via 
binding partners, such as the scaffolding protein, caveolin-1, which has been shown to 
interact with many proteins, specifically PKA. However, the role of caveolin-1 in PKA 
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inactivation remains unknown.37 In a first step towards elucidating this mechanism, PKA 
binding with cavsol was established with ELISA and ITC experiments. The results 
indicate that PKA binds cavsol with micromolar affinity.  
Thus, future experiments will study how caveolin-1 interacts with PKA tethered to 
a SWCNT device. In addition to caveolin-1, many PKA protein binding partners (e.g., 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nitric oxide 
synthetase (eNOS), Heat-shock factor 1) exist and the method through which they bind 
to PKA is not well understood.38 Furthermore, if the electronic signal from inhibition 
studies of PKA with other proteins prove difficult to distinguish, then known small-
molecule kinase inhibitors can be used.21,39 
 In addition to regulation by other proteins, a cluster of posttranslational 
modifications at the N-terminus may fine-tune enzyme activity, regulation, and 
localization. For example, myristoylation may actively participate in protein kinase 
activation or deactivation and may tune different signaling events regulated by these 
enzymes.40-43 Currently, this has only been researched with ensemble experiments, 
where there are too many molecules in solution to get accurate enzyme dynamic and 
kinetic information. However, the SWCNT-FET technique can be utilized for further 
understanding of this mechanism at a single-molecule level. This innovative single 
molecule technique can also be used to measure the promiscuity of single PKA 
molecules as a model system for other kinases. 
2.10 Materials and Methods 
 All chemical reagents were purchased from Fisher Scientific, Thermoscientific, 
EMD, Sigma Aldrich or Acros Organics, and were used as received unless otherwise 
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specified. Oligonucleotides in Table S1 were ordered from GENEWIZ, Inc. All cell lines 
were purchases from Stratagene. The pET28c vector with PKA sub-cloned was 
provided by Dr. Issa Moody.  
Oligonucleotides for overlap extension PCR for PKA variants 
PKA-T32C-F: 5'-GAAAAAATGGGAGCTTCTCAGAATAC-3' 
PKA-T32C-R: 5'-GTATTCTGAGAAGCTCCCATTTTTTC-3' 
Wild-Type PKA-F: 5'-CATGCCATGGCAGCAACGCCGCCGCC-3' 
Wild-Type PKA-R: 5'-CCGCTCGAGCGGCACTCCTTGCCACA-3' 
Protein Kinase A mutagenesis: 
 A mutation introduced into the gene encoding protein kinase A (PKA) placed a 
free thiol on the protein surface for bioconjugation to the SWCNT. This mutation, T32C, 
was synthesized using the DNA sequence for the core catalytic domain of wild-type 
PKA as a template for splice overlap extension PCR using the primers PKA-T32C-F and 
PKA-T32C-R (Table S1). A second round of PCR was carried out using the primers 
Wild-Type PKA-F and Wild-Type PKA-R  (Table S1). The subsequent DNA sequence 
encoding T32C PKA variant was then sub-cloned into the pET28 vector for protein over-
expression  
Protein Kinase A expression and purification: 
 The T32C PKA variant was over-expressed in E. coli using the following 
representative protocol. After transformation of the pET28-T32C PKA plasmid into E. 
coli BL21 (DE3) cells, agar plates supplemented with kanamycin (40 µg/mL) were 
incubated overnight at 37 °C. The following day, a single transformed colony was grown 
overnight in LB media (5 mL) supplemented with kanamycin (40 µg/mL). The starter 
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culture (5 mL) was used to inoculate LB media (1L) before incubation at 37 °C, and the 
culture was grown to an OD600 of 0.8 before induction with 500 µM IPTG. Next, the 
culture was grown overnight at 23 °C shaking. The culture was then centrifuged at 6 
krpm (4032 g) for 25 min at 4 °C, and the supernatant was decanted. The cell pellet was 
resuspended in 15 mL low salt lysis buffer (20 mM Tris, 10 mM NaCl, pH 7.2) before 
cell lysis by sonication. The resultant cell culture was centrifuged at 16 krpm (17203 g) 
for 45 min at 4 °C. Subsequently, the supernatant was decanted and filtered through a 
0.45 µm pore size filter. The cell lysate was applied to a cation exchange column on a 
BioLogic DuoFlow FPLC. The purified T32C PKA fractions were concentrated by 
ultrafiltration with a 10 kDa cutoff microconcentrator and applied to a Superdex size-
exclusion column.  The T32C variant of PKA was eluted in PBS buffer (138 mM NaCl, 
2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2). Another protocol adapted 
from advice from Michael Deal (in Dr. Susan S. Taylor's laboratory at University of 
California, San Diego) applied weak and then strong cation exchange chromatography 
for purification. As shown by the 15% SDS-PAGE, the resultant protein was >99% 
homogenous. 
Protein Kinase A Activity Assay: 
 The PKA activity assay applied a previously reported protocol.21 From the results, 
it can be concluded that wild-type PKA activity is demonstrated by a decrease in 
absorbance as compared to the absorbance of the reaction with no PKA present. Wild-
type PKA has similar activity to T32C PKA. 
SWCNT Synthesis and Device Fabrication 
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SWNTs were grown by chemical vapor deposition (CVD) directly onto 4” Si wafer 
using standard techniques.17,18 In our implementation, a 0.1% dilution of a saturated 
solution of FeMo catalyst nanoparticles in ethanol was spin-coated onto a wafer 
surface.17,18 The deposited catalyst clusters were oxidized at 700 °C (air, 600 s), then at 
940 C (520 sccm H2 in 3000 sccm, 300 s), and then exposed to carbon feedstock (1000 
sccm CH4, 520 sccm H2, and 3000 sccm Ar, 180 s). 
After CVD, SWCNT electronic devices were built.  Ti electrodes with source-drain 
separations of 2 to 3 µm were patterned on the randomly-grown SWCNTs using optical 
lithography with an undercut bilayer resist (S1808 over LOR-A1, MicroChem). The 
device was electrically probed and characterized. To ensure that the device comprises 
only one SWNT, to determine the diameter of the SWNT, and to discern that the SWNT 
is free of particulates, the device was imaged by non-contact atomic force microscopy 
(AFM, NT-MDT). 
After initial characterization, the device underwent a passivation step to insulate 
the majority of the surface including the source and drain electrodes from the protein 
conjugation and measurement solutions.  The device was coated with an electron beam 
resist (A3 PMMA), and then patterned using electron beam lithography to expose an 
active SWNT window of 0.5 – 1.0 µm in length. 
Protein Conjugation: 
A bi-functional linker molecule, pyrene maleimide, was used to functionalize the 
SWNT of the device. The device was submerged in a saturated solution N-(1-
pyrenyl)maleimide in ethanol for 45 minutes without agitation. Next, the device was 
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rinsed with 0.1% Tween-20 in ethanol to remove excess N-(1-pyrenyl)maleimide and 
then rinsed with de-ionized water. 
PKA conjugated to the SWNT. A solution of PKA (52 µM) in phosphate buffer 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 2 mM MgCl2, 2 mM ATP, 
100 μM TCEP, pH 7.4) was prepared. The MgCl2 and ATP are used to sterically block 
bonding to cysteines (C199, C343) located near the active site of the protein.  The 
device was soaked in the protein kinase solution for 60 min without agitation at room 
temperature.  The device was then rinsed with phosphate buffer and soaked in another 
solution (100 mM NaCl, 20 mM Na2HPO4, pH 2.5) for 1 min with gentle shaking to 
remove non-specifically adsorbed protein from the surface of device.  Next, the device 
was rinsed and stored in a buffered aqueous solution (100 mM MOPs, 9 mM MgCl2, 
100 μM TCEP, pH 7.2) 
To confirm protein conjugation before the electrical measurement, the device 
was imaged by liquid atomic force microscopy (NT-MDT) in the buffered aqueous 
solution.   
Electrical Measurements: 
All measurements were performed with the active portion of the device 
submerged in buffered aqueous solution (pH 7.2). The potential of the electrolyte was 
controlled using Pt counter and reference electrodes, and held at -0.3 V vs. Pt using a 
Keithley 2400 sourcemeter.  The source-drain bias was held at 100 mV. A Keithley 428 
preamplifer operating at 108 V/A gain and with a 40 µs rise time was used to measure 
the source-drain current of the device. Data was collected for at least 300 s for each 
measurement condition. 
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Control Electrical Experiments: 
 Control measurements were conducted using a device from the same chip that 
had a successful protein attachment. The control and functionalized devices 
simultaneously underwent the protein attachment protocol, but the control device failed 
to yield an attachment. This device was then electrically measured in the buffered 
aqueous solution (pH 7.2), buffered aqueous solution (2 mM ATP), buffered aqueous 
solution (100 μM Kemptide), and buffered aqueous solution (2 mM ATP, 100 μM 
Kemptide). No processive fluctuations from the baseline were observed. 
ELISAs:  
ELISAs were used to assess protein-protein binding interactions as previously 
described.44 Target proteins were coated on a 96-well plate at a concentration of 10 
µg/mL. The plates were blocked with 0.2% nonfat milk (NFM), bovine serum albumin 
(BSA), ovalbumin, or casein, and the indicated concentrations of cavsol in PBS 
supplemented with 0.2% nonfat milk and 0.05% Tween-20 were added. A mouse anti-
His6 epitope primary antibody (Sigma) and an anti-mouse horseradish peroxidase 
(HRP) conjugated secondary antibody (Sigma) were added to detect the presence of 
bound protein.   
Isothermal Titration Calorimetry 
ITC experiments were performed on a Malvern Microcal VP-ITC instrument. Five 
injections of 5 µL followed by thirty three injections of 7 µL of 300 µM cavsol were added 
via a microsyringe in 400 s intervals to a solution of 73.5 µM PKA with stirring at 307 
rpm in 50 mM tris-HCl, 5 mM 2-mercaptoethanol, pH 8.0 at 20 °C. The experimental 
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data were obtained from fitting the titration curve using the Origin software provided with 
the instrument. 
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Chapter 3: Improving the Cysteine-Maleimide Bioconjugation for 
SWCNT-FETs 
3.1 Abstract   
Frequently, nanotechnology and biophysics experiments require biomolecules 
anchored to a surface. For example, numerous sensing techniques feature enzymes 
and binding partners conjugated to electronic devices. The venerable thiol-maleimide 
bioconjugation often forms key bonds in such devices. In this reaction, a maleimide 
undergoes a Michael addition reaction with a cysteine residue’s free thiol within a 
protein of interest. The reaction’s rapid connectivity, attachment site flexibility, and 
operational simplicity make it widely employed. Despite its advantages, the thiol-
maleimide reaction can suffer from unexpectedly low yields and poor reproducibility. We 
have identified and investigated factors contributing to poor thiol-maleimide 
bioconjugation of single-walled carbon nanotubes (SWCNTs) used for bioelectronic 
measurements.  This study optimizes conditions for surface attachments to SWCNTs, 
including protein purity, reaction time, detergent, other additives, and salt concentration. 
For example, the reducing agent tris(2-carboxyethyl)phosphine (TCEP), which is used 
to abate thiol oxidation, also readily reacts with maleimides. We introduce a TCEP-
compatible, maleimide analog to solve this problem, and provide its facile and near-
quantitative synthesis. Furthermore, protein attachments to SWCNTs with N-(2-
anthryl)maleimide (anthracene maleimide) improve yields versus N-(1-
pyrenyl)maleimide (pyrene maleimide), a ubiquitous reagent for attachments to carbon 
nanotubes and graphene. The conditions reported here could guide improved 
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reproducibility and reliability for all bioconjugation strategies requiring the thiol-
maleimide reaction. 
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3.2 Introduction 
Nanomaterials have size ranges comparable to the scale of biomolecules 
including DNA (2-3 nm wide), proteins (1-100 nm diameter), and lipid membranes (~5 
nm thick).1 Carbon allotropes like SWCNTs offer analogous sizes to biological 
molecules. The synergy conferred by integration of biomolecules into nanometer-scale 
materials has paved the road to powerful new sensing technology. For example, 
biomolecules attached to SWCNTs appear in environmental,2 medical,3,4 and chemical5 
nano-scale devices, such as fuel cells, drug delivery agents, and sensors, respectively. 
These technologies share a common design, in which SWCNTs are modified with a 
molecule responsive to the presence of a specific analyte. The surface-modified 
SWCNT can switch through various conductance states as the analyte binds and 
unbinds to the attached biomolecule, potentially yielding quantitative measurements.6 
The natural specificity and affinity of proteins, including enzymes and antibodies, make 
them superbly well-suited to confer molecular recognition to SWCNT-based sensors.7-10 
The sensing protein can be attached to the SWCNT surface either covalently11 or 
noncovalently.12  
Noncovalent attachments to the SWCNT are generally preferred as such 
association can preserve the band structure of carbon nanotube and lifetime of the 
device.13,14 Conversely, direct covalent attachment can disrupt the electrical properties 
upon which the device depends.15,16 A commonly employed noncovalent attachment 
strategy to SWCNTs applies a pyrene molecule linked to an appropriate reactive 
handle. For example, pyrene-based linkers bearing a maleimide13 or activated ester17 
functional group can provide stable anchors to the sidewall of the SWCNT. The 
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protein’s surface-exposed cysteine or lysine residues can react with the linker 
functionalities for SWCNT sensitization. 
The SWCNT sidewall functionalization step (Figure 3-1) can be a significant 
bottleneck to an active device. Work in our laboratories towards dissecting enzyme 
dynamics at the single-molecule level18 has been slowed by the capricious nature of 
thiol-maleimide attachment protocols. These considerations motivated a thorough 
investigation of factors affecting this reaction and consequent protein-nanotube 
attachment yields (Figure 3-1). 
 
Figure 3-1. Schematic diagram, not to scale, showing protein conjugation to carbon 
nanocircuits. a) Pyrene maleimide (1), anthracene maleimide (5), and anthracenyl 
dimethylmaleimide (6) adheres firmly to the SWCNT sidewall via π-stacking 
interactions; b) The protein (blue) with a single thiol reacts covalently with the 
maleimide linker. 
 
The thiol-maleimide reaction has a distinguished heritage in molecular assembly 
and reactivity. In 1938, Morgan and Friedmann reported that the thiols of glutathione, 
thiolacetic acid and cysteine were consumed through reaction with maleic acid.19 This 
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specific reaction with maleic was then applied to the inhibition of enzymes requiring free 
thiols.20 This type of inhibition is still in use today, and is the mechanism for several 
antibacterial agents and other therapeutics.21 Maleimides replaced maleic acid in 1949, 
due to their >100-fold faster reaction rates with thiols,22 and were used frequently soon 
thereafter in histochemical characterizations.23 Maleimides, however, react with 
nucleophiles other than thiols, including phosphines.24-32 The 1996 Handbook of 
Fluorescent Probes and Research Chemicals33 advertised the phosphine reducing 
agent TCEP34,35 as being compatible with the cysteine-maleimide reaction.26,32,36 This 
claim has since been discredited,37-39 and does not appear in more recent editions of the 
Handbook. TCEP reacts rapidly with maleimides even at pH 5.0,38 considerably below 
the pKa of the phosphine
31 (7.65 ± 0.03) (Figure 3-2). We observed better yields of 
protein-conjugated nanodevices following extensive dialysis to remove TCEP from the 
reaction mixture.  
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Figure 3-2. Titration of TCEP hydrochloride. There are four acidic protons per TCEP 
molecule. Three of the acidic protons belong to the three alkyl carboxylic acid 
substituents, and the other belongs to the protonated phosphine. The pKa of the 
protonated phosphine was determined through a polyprotic acid titration (a), as follows. 
TCEP·HCl (200 mg) was dissolved in 100 mL distilled water. The acidic solution was 
titrated by slow addition of 0.1 M aqueous KOH solution at 24 °C. Changes in pH were 
monitored with a glass electrode (b). Points of inflection were estimated from ΔpH/ΔV 
and Δ2pH/ΔV2 plots (c and d, respectively). The pKa was measured as the pH at the 
midpoint between the two points of inflection, and was read directly from the plot in b. 
The pKa of the phosphine was determined to be 7.65 ± 0.03, where the error represents 
3 standard deviations (3σ) from the mean of three independent measurements. This 
result is in good agreement with that reported by Podlaha31 (7.66 ± 0.04). Plots b-d are 
comprised of the data obtained from all three experiments. 
The thiol-maleimide reaction features prominently in our prior work with individual 
protein molecules attached to single-walled carbon nanotube (SWCNT) field-effect 
transistors. In this approach, a single cysteine variant of the protein is engineered to 
61 
 
ensure the presence of a single thiol functionality for bioconjugation to pyrene 
maleimide.18,40 The aromatic pyrene of this linker can strongly adhere to the SWCNT 
sidewall via hydrophobic and π-π interactions.41,42 Low protein concentration and 
careful control over exposed surface areas of SWCNTs ensures an average of one 
protein attachment per device.18,40 Atomic force microscopy (AFM) images can confirm 
the attachment of one protein molecule to the SWCNT. In principle, any molecule of 
interest can be directly tethered to a SWCNT using this scheme. Thus, improving 
bioconjugation protocols is critical to successful device fabrication and implementation. 
3.3 Variables affecting cysteine-maleimide reaction 
Though important for our SWCNT attachments and in many other 
applications,43,44 the thiol-maleimide reaction poses numerous challenges to 
experimenters. Here, we identify these problems before describing general conditions 
offering improved yields and reliability for nanocircuit device fabrication. In single 
molecule experiments, the two components, protein and SWCNT, are present at very 
low concentrations. Inefficient reactivity, side reactions, or insolubility can limit reaction 
yields.  
The maleimide linkers, including pyrene maleimide (1), are only vanishingly 
soluble in anhydrous ethanol and insoluble in aqueous buffers. Ethanol is one of the few 
organic solvents compatible with polymers used to passivate the electrical contacts of 
SWCNT devices, including poly(methyl methacrylate), polydimethylsiloxane, and SU8. 
However, ethanol reacts with 1 to form the more soluble, ethoxysuccinic ethyl ester. We 
observe this transformation occurring in anhydrous ethanol stored in glass vials without 
added reagents (Figure 3-3). Such conditions are considerably milder than previously 
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reported for this reaction.45-47 This undesirable side reaction between 1 and ethanol 
could limit attachment yields by consuming available reagent, especially in the context 
of devices based on low density SWCNTs. The soluble fraction of 1 is completely 
decomposed to the double ethanol adduct in 12 h at room temperature.  
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Figure 3-3. 1H and 13C NMR detection of the double ethanol adduct of pyrene 
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maleimide. 
Though commercially available and used extensively, if not exclusively, linker 1 
could be replaced for further gains in bioconjugation efficiency. Anthracene has similar, 
if not slightly greater binding affinity to SWCNTs than does pyrene.48 We measured a 
three-fold improved solubility of 5 compared to 1 in ethanol; 1 was soluble at 1.0 mM in 
ethanol at 25 °C while 5 was soluble at 3.5 mM in ethanol at 25 °C. Synthesis of 5 
proved challenging. 
In standard approaches to the synthesis of N-arylmaleimides, an arylamine and 
maleic anhydride are heated under acidic, dehydrating conditions. Unfortunately, maleic 
anhydride and maleimide are extremely efficient dienophiles, and undergo rapid Diels-
Alder cycloadditions with anthracene at elevated temperatures.49 To avoid this 
undesirable cycloaddition, mild conditions were developed for the syntheses of target 
maleimides 5 and 6 (Figure 3-4). The maleamic acid 3 was prepared by ring-opening 
acylation of maleic anhydride with 2 in anhydrous THF at 25 °C. Compound 3, which 
readily precipitates from the reaction mixture as a bright orange solid, was then 
converted into the methyl ester 4 in MeOH/SOCl2, also without heating. Cyclization of 4 
was achieved under phase transfer conditions in a mixture of CHCl3 and H2O/Na2CO3 at 
ambient temperature.50 The dimethyl derivative 6 was inaccessible via this route, as no 
reaction was observed between dimethylmaleic anhydride and 2. To encourage 
formation of the dimethylmaleamic acid, the acylation catalyst DMAP was employed, 
and the reaction solvent was changed to a 2:1 mixture of CH2Cl2/DMF. Surprisingly, 
these conditions bypassed the intermediate dimethylmaleamic acid, delivering 6 directly 
and in near-quantitative yields. 
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Figure 3-4. Synthetic scheme for 
synthesis of maleimide derivatives. a) 
Pyrene maleimide 1, b) Scheme for the 
synthesis of 5 and 6. Reagents and 
conditions: i) maleic anhydride, THF, rt, 
24 h; ii) SOCl2, MeOH, rt, 36 h; iii) 
tetrabutylammonium bromide, Na2CO3, 
CHCl3/H2O, rt, 1 h; iv) dimethylmaleic 
anhydride, DMAP, DMF/CH2Cl2, rt, 24 
h. 
Atomic-force microscopy (AFM) confirmed successful protein-SWCNT 
attachment using the maleimide linkers 1, 5 and 6 (Table 3-1). Particles with sizes 
consistent with protein structural data were counted as attachments (Figure 3-5). Three 
proteins were used in the investigation: DNA-polymerase Klenow fragment (KF), T4-
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lysozyme (T4L), and dihydrofolate reductase (DHFR). Compound 5 yielded consistently 
higher attachment levels than 1 for all three proteins, as judged by AFM. The relative  
Table 3-1. Attachment efficiency of proteins (50 nM) to SWCNT-FET devices.a 
Linker: 1 5 6 
[NaCl] (mM) 150 300 150 300 300 
TCEPb + − + − + − + − + − 
T4Lc 0.25 0.33 0.43 0.50 0.12 0.22 0.32 0.67 0.48 0.31 
DHFRd n.d. 0.22 n.d. 0.21 n.d. n.d. 0.00 0.64 1.11 0.00 
KFe 0.22 0.45 0.54 0.60 0.24 0.34 0.45 0.76 0.34 0.13 
a Quantified by protein-sized particles attached per µm of SWCNT; b [TCEP] = 100 µM; 
 c 2.5-3.5 nm particle size; d 2.5-4.0 nm particle size; e 4.0-7.0 nm particle size. 
 
 
Figure 3-5. AFM imaging of protein attachment to carbon nanocircuits. Visualization of 
a) T4L, b) KF, or c) DHFR proteins conjugated to SWCNTs demonstrates yields of 
single and rarely double attachments. Line scan analysis of d) T4L, e) KF, or f) DHFR 
identifies protein-sized particle between the white arrows. 
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rates of reaction were investigated for compounds 1 and 5 by time-course NMR using 
ß-mercaptoethanol was used as a model thiol (Figure 3-6). No significant difference in 
reaction rates was observed, suggesting that the gains in attachment yields are 
predominantly owed to the increased solubility of 5 compared to 1. In a failed attempt to 
improve device yields by increasing the density of linkers π-stacked on the SWCNT, 
mixtures of anthracene maleimide and pyrene maleimide precipitated onto the device 
surfaces; no successful bioconjugations could be imaged from such precipitate-coated 
devices.  
 
Figure 3-6. Time-course NMR for the reactions of β-mercaptoethanol with 1 and 5. 
Time-course NMR was performed on a Bruker Avance 600 MHz CryoProbe™ 
spectrometer, as follows. A solution of 1 or 5 (400 µL, 150 mM in DMSO-d6) was 
combined with a solution of ethylene carbonate (150 µL, 400 mM, in DMSO-d6), in a 0.5 
mm OD NMR tube. The sample was heated to 325 K, the receiver coils were tuned, and 
the sample lock and shim were optimized with the sample spinning at 20 Hz, and a 
spectrum at t0 was collected. Then, the sample was ejected, and a solution of β-
mercaptoethanol (BME) (150 µL, 400 mM in DMSO-d6) was added. The sample tube 
was inverted several times to mix thoroughly, and then placed back in the spectrometer. 
The final reaction volume was 700 µL, and final concentrations of maleimide, ethylene 
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Next, TCEP-resistant structural analogs of maleimide were explored to avoid 
oxidation of the cysteine thiol. High concentrations of TCEP (up to 100 mM reported) 
likely consume conventional maleimides 
through formation of phosphine ylides (Figure 
3-7).27-29,36  We reasoned that compound 6, 
the 2,3-dimethyl derivative of 5, would be 
unable to react with TCEP due to its lack of 
abstractable protons required for phosphine 
ylide formation. Since compound 6 retains 
electrophilicity for thiol groups, the 
bioconjugation should remain unaffected by 
addition of TCEP to protein solutions. 
Dimethyl maleimides and monomethyl 
maleimides (citraconimides) are slower to react than their unsubstituted cousin; 
however, their thiol adducts benefit from improved hydrolytic stabilities.51,52 For 
biosensor construction, longer reaction times (up to 10 minutes) are easily tolerated, 
and offset, by improved device lifetimes. Though the dimethylmaleimide linker 6 
improves device stability and simplifies fabrication through tolerance of TCEP, it also 
carbonate, and BME were 90.0 µM, 100 µM and 100µM, respectively. The sample 
shimming was then quickly reoptimized and the first spectrum was collected at 5 and 3 
min following BME addition for compounds 1 and 5, respectively. Single-scan 1H NMR 
spectra were collected in 5 min intervals up to a total reaction time of 150 min. Reaction 
progress was determined through comparison of the integration values for the 
maleimide protons (δ 7.3 ppm) relative to ethylene carbonate (δ 4.5 ppm). The 
concentration of ethylene carbonate in the reaction mixture is assumed to be constant 
throughout the experiment, and serves as an internal standard. The results support the 
assertion that there is no significant difference in rates of thiol addition to 1 and 5. 
 
Figure 3-7. Proposed mechanism for 
the reaction and derivatization of 
maleimides by phosphine reducing 
agents, such as TCEP. 
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exhibited decreased solubility in ethanol. Thus, compound 6, in general, exhibited 
decreased protein-SWCNT attachment yields compared to compounds 1 and 5 (Table 
3-1). 
Other variables were investigated for their potential effects on the thiol-maleimide 
reaction. For example, increasing the ionic strength of the buffer can be beneficial to 
protein-SWCNT attachment yields, an effect ascribed to disrupting the hydration shells 
of the protein and the SWCNT.53 For the three proteins reported here, 300 mM sodium 
chloride produced higher attachment efficiency than 150 mM (Table 3-1). Very low (10 
mM) and very high (600 mM) salt concentrations affected protein stability and 
consequent attachment yields (Figure 3-8). Tris(hydroxymethyl)aminomethane (Tris), a 
common buffer in biochemistry laboratories, is reported to slowly react with 
maleimides,45 and should be avoided where possible. However, each protein has its 
own specific buffer, pH, and salt requirements that add considerable weight to the 
choice of attachment conditions. For example, KF proved unstable in phosphate 
solutions, and use of Tris buffer is apparently unavoidable for this enzyme. 
AFM imaging can readily detect biofouling, the buildup of proteinaceous debris, 
on device surfaces. In extreme cases the SWCNT can become completely occluded by 
biofouling. The debris is assumed to be comprised mostly of protein aggregates. This 
hypothesis is consistent with the appearance of fouled surfaces under normally 
denaturing conditions, including extreme salt concentrations. Biofouling is a significant 
source of wastage in device manufacture, as the SWCNTs, silicon chip, and valuable 
protein are all expended for an ultimately useless object. 
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 Conventional methods to limit biofouling and allow successful AFM imaging 
include the addition of detergents. Tween-20, for example, can coat the nanocircuit 
 
Figure 3-8. Examples of AFM imaging to examine the effect of buffer salt concentrations 
on attachment yields and surface fouling. Images in a and b visualize the same device 
surface before (a) and after (b) treatment with lysozyme solution (50 nM) in 50 mM 
NaCl. There are three particles visible attached to the SWCNT as indicated by the black 
triangles. Each particle is between 2.5 – 3 nm in size on top of the SWCNT. The last 
particle at the end of the SWCNT is next to a large aggregate, about 8 nm, on the 
surface. Other particles on the SWCNT not labeled with a black arrow are particles on 
the SWCNT from before the treatment. Also, the AFM tip resolution is much better 
compared to c and d. Images in c and d visualize another device surface before (c) and 
after (d) treatment with a solution of lysozyme in which the salt concentration of the 
buffer was increased to 300 mM NaCl. Protein-sized particles attached to the SWCNTs 
are indicated with black triangles. The higher salt solution results in increased protein 
attachments to SWCNTs, but more non-specific adsorption onto the silica surface is 
also observed. 
 
a b 
c d 
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surfaces to prevent nonspecific adsorption of protein.54 The presence of Tween-20 
(0.1%) in the attachment protocol wash steps proved critical for visualization of proteins 
attached to SWCNTs, decreased random adsorption on the SiO2 surface, and abated 
biofouling in about 65% of experiments (Figure 3-9). Diminished biofouling also 
correlates with an increase in bioconjugation efficiency. 
Protein purification and oligomeric homogeneity also proved essential. 
Rigorously purifying the protein through three chromatography steps, including two 
Superdex size-exclusion chromatography (SEC) columns (P200, then P75), can remove 
aggregates carrying cellular debris. Biofouling and poor attachment yields were 
observed consistently in experiments employing protein samples with even seemingly 
negligible concentrations of aggregates (Figure 3-10). Such aggregates can be 
identified using SDS-PAGE analysis, which assesses protein homogeneity but not 
a b 
Figure 3-9. Observation of the effect of Tween-20 on surface fouling by AFM. 
Surface quality was interrogated by AFM in the absence (a) and presence (b) 
of Tween-20 in the wash buffer, which was used to treat the device surface 
immediately before and after the bioconjugation step. The inclusion of Tween-
20 reduces the amount of surface fouling. 
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oligomeric state. Attachment efficiency dramatically increases when using a 99% 
Figure 3-10. The effect of protein purity on surface biofouling. a) This 
representative FPLC chromatogram of KF (collected at 280 nm) 
illustrates the two peaks separated by the additional SEC step. KF 
isolated from the center of each peak is active in a fluorescence 
activity assay (kcat of 1.67 and 1.01 min
-1 for Peaks 1 and 2, 
respectively). b) Analysis by SDS-PAGE (15% acrylamide) reveals 
the additional impurities co-eluting with Peak 1. c) Dramatically more 
biofouling is observed by AFM imaging for bioconjugation with protein 
from Peak 1. The SWCNT cannot be observed under such biofouling. 
d) The protein collected from Peak 2, however, yields much cleaner 
surfaces, allowing identification of the SWCNT and successful 
bioconjugation (arrows). 
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homogenous protein sample (Figure 3-11). 
Furthermore, attachment yields increased with 
higher protein concentrations. 
However, nonspecific adsorption 
of protein onto the device surface 
occurred more often with higher 
protein concentrations (Figure 3-
12); apparently, the preventative 
Tween-20 treatment can be 
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Figure 3-11. Representative 
SDS-PAGE gel (15%) of 
lysozyme, KF, and DHFR 
proteins used in the 
bioconjugation studies reported 
here. Each lane of the gel 
visualizes 15 µL of proteins at 
1 µM concentration. As shown 
by this gel, all proteins were 
purified to >95% homogeneity 
before bioconjugation 
reactions.  
a 
b 
c 
Figure 3-12. Observation of the effects of 
protein concentration on surface fouling by 
AFM. SWCNT devices were inbubated with (a) 
5 nM, (b) 25 nM, or c) 50 nM lysozyme 
solutions for a period of 1 h. Protein-sized 
particles attached to the SWCNTs are indicated 
with black circles. Higher protein concentration 
increased non-specific adsorption to the silica 
surface. 
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overwhelmed past certain thresholds. The optimal protein concentration (50 nM) 
minimized surface fouling, and allowed rapid bioconjugation; attachments to the 
SWCNT were confirmed after as little as 1 min protein incubation time (Figure 3-13). 
The conditions reported here, including detergents, protein concentration, and 
bioconjugation reaction times, were general and optimal for the three different proteins 
used in these experiments.  
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0 min 
30 min 1 h 
2 min 
3 h 18.5 h 
5 min 
10 min 
2 h 
Figure 3-13. Time-course AFM images for monitoring cysteine-maleimide 
bioconjugation. At the times indicated in bold, the bioconjugation reaction 
solution (either lysoyzme or DHFR at 50 nM concentration) was rinsed and 
then imaged by AFM. Protein-sized particles attached to the SWCNTs are 
indicated with black circles. Protein attachment can be observed within 2 min. 
Furthermore, increased reaction times does not necessarily increase 
attachment yields, but can increase surface fouling. After 18.5 h, protein 
attachments on the SWCNT can be observed, and increased aggregate 
formations on the surface are also apparent. 
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3.4 Electronic measurements 
 Bioelectronic measurements using SWCNT field effect transistors further 
corroborate that the single protein attached via linker 5 remains active and 
demonstrates switching behavior indistinguishable from that obtained with compound 1. 
Previous single protein measurements have demonstrated the motion of the protein 
during its catalytic cycle can induce binary switching in conductance states.13,40 Both 
anthracene and pyrene’s π-π stacking network yields a stacking distance of ~5 Å on the 
SWCNT surface. The maleimide linker and its conjugate addition product remain 
unchanged between compounds 1 and 5. Since both linker molecules tether the protein 
the same distance from the SWCNT, both linker molecules yield identical signal (Figure 
3-14).  Rates of T4L attached with 1 and 5 display identical rates of 15-60 s-1 with 
 
Figure 3-14. Representative current measurement for carbon nanocircuits. a) 
Lysozyme in PBS conjugated via anthracene maleimide to the carbon nanotube does 
not affect the inherent 1/f noise shown here. b) The addition of peptidoglycan, 
lysozyme substrate from M. Luteus, yields the characteristic binary conductance 
switching previously observed for lysozyme conjugation with the pyrene maleimide 
linker. 
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variability attributed to static and dynamic disorder as reported previously.13 
3.5 Conclusion 
In conclusion, a robust thiol-maleimide bioconjugation protocol is presented that 
overcomes the known problems associated with this chemistry. The introduction of 
linker molecule 5 improves SWCNT bioconjugation yields. Improvements in solubility, 
without any sacrifice in SWCNT side-wall affinity, makes 5 a compelling successor to 1 
for the construction of functionalized nanodevices. Additionally, a potential solution to 
the TCEP/maleimide incompatibility problem is offered through the development of 6, 
which is unable to form stable phosphine ylides. Taken together, the improvements 
reported here in linker molecule structures, buffer composition, and protein 
characteristics address a bottleneck in nanocircuit device fabrication. These pitfalls and 
their solutions are applicable to all devices and materials reliant upon thiol-maleimide 
reactions. 
3.6 Materials and Methods: 
Functionalization of carbon nanotubes: 
SWCNT-FETs were fabricated and functionalized with a single-cysteine variant 
of three different model proteins, A) T4 lysozyme (T4L) variant with the substitutions 
C54T/C97A/S90C, B) exonuclease-deficient DNA Polymerase 1 Klenow Fragment (KF) 
variant with the substitutions D355A/E357A/L790C/C907S, and C) Dihydrofolate 
Reductase (DHFR) variant with the substitution G121C.  
Protein purification: 
Each protein was purified to >99% homogeneity as follows. T4L has an 
isoelectric point (pI) of 9.1, giving it an overall positive charge. Thus, it was purified 
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using strong cation exchange chromatography, which has a negatively charged resin. 
T4L can be eluted from the column by changing the ionic strength of the buffer. KF and 
DHFR both are 6x His-tagged and subsequently purified using Ni-charged IMAC resin. 
KF and DHFR were both eluted with 250 mM imidazole, concentrated, and then treated 
with TEV protease for two days at 4 °C.  For ~99% homogeneity of all three proteins 
(T4L, KF, and DHFR), size-exclusion chromatography was used for further purification 
(Figure 3-11).  
Protein activity assay:  
Fluorescence-based assays confirmed the activity of the bulk enzymes prior to 
their attachment to SWCNTs. During bioconjugation, the devices were soaked in a 
solution of either N-(1-pyrenyl)maleimide (1 mM in ethanol, 30 min) or 4 (3 mM in 
ethanol, 30 min), followed by incubation with one of the three proteins (50 nM protein in 
a standard activity buffer for each protein). For T4L and DHFR attachment, the buffer 
was PBS (138 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.5), for 
KF the buffer consisted of 20 mM Tris, 50 mM NaCl, 10 mM MgCl2, 100 µM TCEP, pH 
8.0. Atomic force microscopy after data collection confirmed attachment of a single 
protein molecule to each device (Figure 3-5). Finally, the device was rinsed with wash 
buffer (PBS with 0.1% Tween-20).  
Electrical measurements: 
Once bioconjugated, the lysozyme–SWNT devices were electrically monitored 
for 10 to 20 min in PBS solutions in the presence and absence of Micrococcus luteus 
peptidoglycan (Sigma-Aldrich). The electrolyte potential was held constant at a bias of 
−0.1 to −0.3 V (versus a Pt qausi-reference electrode), which was chosen to maximize 
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the signal-to-noise ratio for each device. 100 mV was applied across the source and 
drain terminals to drive a DC current, I(t), in the SWNT channel. Fluctuations in this 
current were monitored using an externally mounted 40 kHz current amplifier (Keithley 
428) sampling at 100 kHz.  
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Chapter 4: Bioconjugation of Hen Egg-white Lysozyme by Unnatural 
Amino Acid Incorporation  
4.1 Abstract  
SWCNT-FET devices are a powerful tool for understanding protein kinetics and 
dynamics. Typically, the technique relies on unique and benign cysteine substitutions 
for site-specific protein attachment to the SWCNT through thiol-maleimide chemistry. 
However, the use of the thiol-maleimide bioconjugation method limits the scope of the 
technique to only proteins that do not contain functionally important native cysteine 
residues or disulfide bonds. In this chapter, azide incorporation is used as a general and 
novel orthogonal bioconjugation strategy for protein immobilization on SWCNT-FET 
devices. Specifically, an azide-bearing amino acid p-azidophenylalanine (pAzF) is 
genetically incorporated into recombinantly expressed Hen egg-white lysozyme 
(HEWL). By careful screening of experimental conditions, we obtain high protein yields 
and up to 80% UAA incorporation for HEWL. The pAzF labeled HEWL is conjugated by 
“click” chemistry with an alkyne-bearing acceptor. Using this attachment method, we 
successfully tether HEWL to SWCNT, demonstrating the viability of this bioconjugation 
protocol for SWCNT-FET devices.  
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4.2 Introduction 
Bioconjugation is a crucial step for the fabrication of many devices, including 
enzyme-linked SWCNT-FET nanocircuits (discussed in Chapters 1 and 3). Due to 
widespread applicability, a constant need exists for the optimization and development of 
bioconjugation methods. In order for such bioconjugate chemistry to be feasible, certain 
conditions must be met by the chemical reaction employed. Most importantly, the 
chemistry must be compatible with a biological setting. Specifically, the reaction must 
proceed at fast rates under physiological conditions (typically at 37 °C and pH ∼7) and 
unreactive towards any other chemical functionalities of biological systems.1 While a 
range of bioorthogonal reactions have been elucidated, several issues preclude their 
widespread use.2  
These bioorthogonal reactions include copper-catalyzed cycloaddition, ring-strain 
catalyzed cycloaddition, modified Staudinger ligation, Diels−Alder cycloaddition, 
thiol−ene additions, and oxime ligation (Figure 4-1).3-10 The reaction of terminal or 
internal alkynes with organic azides results in a 1,2,3-triazole. The copper-catalyzed 
Huisgen 1,3-dipolar cycloaddition of azides and alkynes,10-12 is an archetypal example 
of „click‟ chemistry (Figure 4-1a). The intrinsic toxicity of copper to cells, aggravated by 
copper-induced protein precipitation greatly limited its full application to in vivo or in vitro 
systems.13 Thus, a copper-free Huisgen cycloaddition was developed. By cleverly 
making use of the release of ring strain energy of a cyclooctyne group, the click reaction 
can proceed without the need of an additional catalyst (Figure 4-1b).14 In a modified 
Staudinger ligation, popularized by the Bertozzi group, an ester group is strategically 
placed on one of the phosphine‟s aryl substituents,11,15 and subsequently transferred to 
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the azide nitrogen. The overall result is the formation of a stable amide bond (Figure 4-
1c).  
Diels−Alder cycloadditions occur between an electronically matched pair of a 
dienophile and a conjugated diene to form a substituted cyclohexene (Figure 4-1d).16 In 
the „thiol−ene‟ reaction, the addition of a thiol to an alkene group occurs via a radical 
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mechanism started either by a radical initiator or by light (Figure 4-1e).12 A disadvantage 
of this ligation method is that thiols can undergo disulfide exchange with disulfide 
bridges, resulting in possible cross reactions with other proteins. Lastly, „oxime ligation‟ 
refers to the condensation of an oxyamine or hydrazide with an aldehyde or ketone to 
provide a stable oxime linkage (Figure 4-1f).17 The recent discovery of aniline as a 
catalyst of this reaction was crucial to extending the utility of this reaction, even at 
neutral pH.4,18,19 All of these methods, except the thiol-ene reaction, requires the 
introduction of a novel and unnatural functionality into the protein which is usually 
accomplished via the site-specific incorporation of UAAs.20  
4.3 UAA incorporation and bioconjugation applications using UAAs 
Recombinant methods have been used to incorporate UAAs into proteins as 
chemical handles for bioorthogonal conjugation reactions.21 This approach is particularly 
attractive because, UAAs can be incorporated at any desired position in any protein. 
Then, site-specifically modified proteins can be expressed recombinantly in high yields 
in bacteria, yeast, or mammalian cells, and require little additional manipulation for 
further conjugation. 11,22-24 
Multiple techniques exist for the introduction of UAAs that range from completely 
synthetic to exploitation of endogenous translational machinery (Figure 4-2).21,24,25 The 
residue-specific method utilizes bacterial auxotrophic strains and exogenous UAA to 
incorporate the UAA in place of a native amino acid (Figure 4-2a). The evolution of 
orthogonal aminoacyl-tRNA synthetase/tRNA (aaRS/tRNA) pairs has found a wide 
degree of success for UAA incorporation at a unique codon, usually an amber stop 
codon (Figure 4-2b).21 Lastly, the semi-synthetic method acylates a suppressor tRNA 
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with the UAA before addition to the expression system for UAA incorporation at a stop 
codon (Figure 4-2c). In this chapter, site-specific UAA incorporation using orthogonal 
tRNA synthetase and tRNA are used due to availability of required reagents.  
Specifically, several experiments use UAAs to generate well-defined 
bioconjugates. For example, azide functionality was incorporated into calmodulin using 
site-specific UAA labeling with azidotyrosine. The functionalized calmodulin was 
conjugated onto amino groups generated at the ends of carbon nanotubes via the 
  
 
  
Residue-specific 
incorporation 
 
  
Site-specific 
incorporation 
 
Orthogonal tRNA 
synthetase and 
tRNA pair  
 
  
Semi-synthetic 
method 
Figure 4-2. Incorporation of unnatural amino acids into proteins. a) Residue-
specific incorporation requires only the addition of exogenous unnatural amino 
acid. The unnatural amino acid is charged onto the cellular tRNA by the 
endogenous tRNA synthetase and incorporated into proteins instead of the 
wild-type amino acid. b) Site-specific incorporation requires an exogenous 
tRNA and tRNA synthetase pair which function orthogonally to the cellular 
machinery. The exogenous tRNA synthetase charges the unnatural amino acid 
onto its cognate tRNA which recognizes a unique codon like a stop codon or a 
4-base codon on the mRNA being translated. c) Semisynthetic incorporation 
makes use of chemical or enzymatic acylation to charge a suppressor tRNA 
with the unnatural amino acid. This is added to the translation system, and is 
inserted at a unique site such as a stop codon. 
a b c 
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Staudinger-Bertozzi ligation.26,27 This study demonstrated successful protein attachment 
to SWCNTs without disruption of protein function. The utility of site-specific attachment 
to SWCNT is crucial for developing biosensors. Similar bioconjugation schemes can be 
applied to many other nanomaterials.28  
4.4 Application of bioconjugation reactions to SWCNT-FETs and their limitations 
Currently, as described in Chapters 2 and 3, thiol-maleimide chemistry (Figure 4-
3) is used to conjugate a single protein molecule onto SWCNT-FETs devices. As stated 
before, this strategy is feasible only for proteins containing one cysteine. If the protein of 
interest contains a large number of native cysteines, they would need to be 
systematically substituted by another residue. Thus, engineering the cysteine at the site 
of interest for labeling can be a time-consuming substantial effort; such engineering can 
also disrupt protein folding. In fact, the mutation of a large number of native cysteines 
increases the likelihood of disrupting a protein‟s native structure, stability, or function. 
Moreover, many proteins rely on native cysteines for critical functions such as enzyme 
catalysis, redox reactivity, conserved disulfide bonds, and binding of essential metal-ion 
cofactors.29,30 These considerations limit applications of the venerable thiol-maleimide 
reaction.  
The goals of expanding new attachment chemistry are to site-specifically attach a 
protein to a SWCNT nanocircuit and interrogate different functional domains or sites of 
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catalysis. As explained in Chapter 3, the pyrene maleimide linker is the preferred 
method of attachment, because no defects need to be introduced in the carbon 
nanotube. However, bioconjugate methods for attaching the pyrene to a protein are 
limited. Thus, to apply the nanocircuit technique to a broad range of proteins and 
overcome the limitations of the current attachment chemistry (discussed in Chapter 3), 
we investigated the azide-bearing UAA pAzF and a clickable linker molecule as a new 
bioconjugation method for SWCNT-FET.  
The protein tested as a model system for exploring this bioconjugation method is 
HEWL, a glycoside hydrolase (14.5 kDa) that degrades peptidoglycan from bacterial cell 
walls. Although HEWL is a glycoside hydrolase like T4 lysozyme, there is only 23% 
structural homology, and both proteins use different catalytic mechanisms (HEWL uses 
a retaining, and T4L uses an inverting mechanism).31 We have previously attached T4L 
with the thiol-maleimide reaction to study on SWCNT-FETs (Chapter 3). However, 
HEWL could not be studied on the nanocircuits with the traditional maleimide chemistry 
as its structure relies upon four disulfide bonds. Thus, functionalization of HEWL with an 
azide moiety via UAA incorporation would allow site-specifically labeling of a protein for 
single-molecule studies.  
To achieve UAA incorporation, a stop codon is inserted at the position coding for 
the residue of interest using conventional site-directed mutagenesis. To date, only the 
TAG (amber) stop codon has been used. Separately, a tRNA that recognizes the amber 
stop codon – a suppressor tRNA – is prepared and chemically acylated with the desired 
unnatural amino acid. These two species are then added to an appropriate translation 
system. Naturally occurring nonsense suppression had been known for some time. 
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Hecht and co-workers32 developed key methodology for preparing misacylated tRNAs 
for incorporation of the UAA, N-acetylated phenylalanine. Schultz and co-workers33 
reported the first successful experiments of incorporating multiple UAAs into β-
lactamase using the semi-synthetic method. Chamberlin and co-workers22 also reported 
early successes with incorporating iodotyrosine into a 16-residue polypeptide at an 
amber stop codon using a pre-acylated tRNA. Today, the site-specific incorporation of 
UAA using orthogonal tRNA synthetase/tRNA pair is a widely applied technique.  
4.5 Investigating an alternative bioconjugation reactions using UAA incorporation 
The CuAAC click reaction was reborn in 2001 when Sharpless34 and Meldal35 
independently reported a Cu(I)-catalyzed variant that proceeds rapidly at room 
temperature to regiospecifically form 1,4-disubstituted 1,2,3-triazoles (Figure 4-1a). 
Since then CuAAC has been heavily employed in bioconjugation applications, small 
molecule library synthesis9 and polymer science.14 For example, fluorescently labeling 
cell surface carbohydrates,36 one pot synthesis of 5-iodo-1,2,3-triazoles, a versatile 
synthetic intermediate,13 and convergent synthesis of dendrimers,14 respectively. 
CuAAC has a faster rate compared to both the aldehyde/ketone ligations and the 
Staudinger ligation. The commercial availability or synthetic accessibility of both 
terminal alkynes and azides have propelled CuAAC to the forefront of chemical biology 
for applications such as labeling of biomolecules in complex mixtures and imaging of 
fixed cells and tissues.37 The advent of oligotriazole ligands has shown that these 
ligands are competent at protecting Cu(1) under aerobic conditions and promoting 
Cu(1)-catalyzed transformations.38 For example, tris-(benzyltriazolylmethyl)amine 
(TBTA)38 was first developed and completely envelopes the Cu(1) center. Then, a more 
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water-soluble ligand was developed, tris(3-hydroxypropyltriazolylmethyl)amine 
(THPTA), further improving the CuAAC reaction.36 Specifically, we are testing a novel 
ligand 1 developed and provided by Valery Fokin and co-workers at USC that combines 
functionalities from TBTA and THPTA to ensure solubility and activity (Figure 4-4).  
 
Anti-Codon  
(Amber Stop 
Codon (UAG)  
 Amino acid 
attachment   
Aminoacyl-
tRNA 
Synthetase 
(pAzF) 
Figure 4-5. UAA incorporation into protein at amber stop codon. pAzF acylated 
onto orthogonal aminoacyl-tRNA synthetase, structure depicting the sites of 
amino acid acylation and amber stop codon.  
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Additionally, previous research has shown successful incorporation of the UAA, 
p-azidophenylalanine (pAzF) into the protein of interest with an orthogonal aaRS/tRNA 
pair from Methanococcus jannaschii (Figure 4-5).21,23,39,40 The first use of pAzF was 
reported by Schultz et al40 demonstrating pAzF incorporation into glutathione-S-
transferase for mapping protein-protein interactions through model cross-linking 
experiments. Since then, pAzF has been incorporated into numerous other proteins due 
to the ease of use with the orthogonal aaRS/tRNA. Therefore, due to the reliable 
CuAAC click reaction and ease of incorporation of pAzF, this bioconjugation method 
was chosen for HEWL.  
4.6 Engineering mutagenesis sites for pAzF incorporation into HEWL 
Since the goal of SWCNT-FET 
technology is to link enzyme function with its 
motion, sites of attachment need to be near 
sites of motion of the enzyme (within 10 Å) 
and not affect catalytic activity.41 For HEWL, 
the selected sites for mutagenesis reside on 
the solvent-exposed surface of the helices. 
The mutation should produce minimal 
perturbation to the protein and accessibility to 
the azide functionality for reaction with 
nucleophiles. Serine at position 99 (S99) and phenylalanine at position 52 (F52) are 
both near the site of catalysis and likely have some rigidity (residues highlighted in 
Figure 4-6).  
Figure 4-6. Crystal structure of HEWL 
(PDB: 193L). Cysteine residues are 
depicted in blue. Sites of 
mutagenesis for pAzF incorporation 
are highlighted (S99, pink) and (F52, 
yellow).  
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4.7 Green fluorescent protein (GFP)-based selection 
Previously, a streamlined scheme utilizing GFP for both positive and negative 
selections was developed by Grabstein et al.42 The method relies on antibiotic 
resistance and the expression of GFP, thus enabling high throughput analysis of various 
conditions. Before testing pAzF incorporation into the HEWL variant, the UAA was 
tested in this GFP expression model system. 
Plasmids encoding for 1TAG GFP, wild-type 
(WT) GFP and pEVOL pAzF aaRS/tRNA 
were provided by Chang Liu and co-workers 
at UCI. Many conditions for the optimization 
of 1TAG GFP expression with pAzF 
incorporation were investigated (Figures 4-7 
- 4-9).  
The 1TAG GFP plasmid was co-
transformed with pEVOL pAzF aaRS/tRNA 
into two different cell lines, a common 
protein over-expression line (BL21 DE3) and 
Church cells. The Church strain was 
specifically engineered to where the TAG nonsense codon has been more rigorously 
reassigned to only encode UAAs by genome-wide substitution of TAG with other 
synonymous stop codons.43 Various expression conditions were tested for optimal 
1TAG GFP expression with pAzF incorporation at the first amino acid position (called 
pAzF GFP from here on). Positive selections for the best conditions were based on the 
Figure 4-7. Image of 96 – deep well 
plate with UAA incorporation into 
GFP. Whole cell analysis shows GFP 
fluorescence in conditions that 
allowed successful incorporation of 
pAzF. The black rectangle shows 
cells with green fluorescence visible 
with a UV light.  
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isolation of green fluorescent bacterial cells (Figure 4-7). Only when pAzF was added to 
the bacterial expression conditions, then green fluorescent bacterial cells were 
visualized by UV light. Thus, 1TAG GFP successfully incorporated pAzF into the first 
position and continued translation of GFP, yielding green fluorescence. If there was no 
green fluorescence observed, then no pAzF incorporated into 1TAG GFP. WT GFP was 
used as a control for basal level of expression of GFP and subsequent fluorescence. As 
seen in Figure 4-7, whole cell fluorescence analysis was simple to detect which 
conditions were optimal for pAzF incorporation and GFP expression. After induction of 
protein expression, the media for the cells was removed and the cell pellet was 
visualized with UV light (Figure 4-7). Then the cells from each test expression were 
resuspended in buffer and fluorescence measurements were read with a plate reader.  
Since GFP has been used as a model system for most UAA incorporation 
experiments, optimal expression conditions for GFP substituted with a new UAA are 
known.42 However, for each new UAA, protein yields, bacterial cell type, and media 
determine incorporation efficiency. As mentioned earlier, pAzF GFP expressions were 
tested in two different cell lines, Church and BL21 DE3 E. coli cells. Another condition 
investigated for successful pAzF incorporation was the type of media used for cell 
growth and GFP expression - Terrific broth (TB), Luria broth (LB), or Minimal M9T 
media (M9T). Further analysis into the data from the GFP test expressions is shown in 
Figures 4-8 and 4-9.  
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Testing the effects of 
media on pAzF GFP expression 
in Church cells is illustrated in 
Figure 4-8. After expression 
and induction, the fluorescence 
readings of the whole cells were 
determined by a fluorescence 
plate reader. Whole cell 
fluorescence was normalized by 
cell density measurement of 
absorbance at OD600 (Figure 4-
8a and b). Comparing pAzF 
GFP expression to WT GFP, in 
the Church strain, pAzF GFP 
expression did not significantly 
increase in any of the media 
tested. TB and LB show slightly 
better normalized fluorescence 
values for pAzF GFP but not to the yields necessary for further experiments. Overall, 
protein expression and pAzF incorporation tested in the Church strain gave low yields. 
This could be due to the sickly nature of the Church strain with codon reassignment 
affecting cell viability.  
 
a 
b 
Figure 4-8. Test expression conditions tested for 
UAA incorporation using GFP in Church cell line. 
a) Fluorescence graph showing expression 
conditions tested. b) Data from fluorescence graph 
tabulated illustrating that Church cell line is not 
ideal for UAA incorporation since all the WT and 
1TAG GFP conditions are very similar.  
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GFP expression with 
pAzF in BL21 DE3 cells 
(Figure 4-9) demonstrates the 
effect of different media on 
pAzF GFP expression. The 
fluorescence data was 
determined by whole cell 
fluorescence analysis 
normalized by a cell density 
measurement of absorbance 
at OD600 (Figure 4-9a and b). 
Using WT GFP growth as a 
baseline, pAzF GFP shows 
four-fold increase and the 
highest normalized 
fluorescence value when grown in LB media. While for M9T media, pAzF GFP has a 
lower normalized fluorescence value compared to WT. The M9T media has limited 
nutrients, thus cells can struggle in this growth condition while trying to incorporate an 
UAA.  
Comparing the GFP test results between both cell lines, BL21 DE3 cells showed 
higher yields of pAzF incorporation into 1TAG GFP as well as cell growth. Comparison 
to the Church cell line was analyzed by normalized fluorescence values (Figure 4-8b 
 
a 
b 
Figure 4-9. Test expression conditions tested for 
UAA incorporation using GFP in BL21 DE3 cells. a) 
Fluorescence graph showing expression conditions 
tested. b) Data from fluorescence graph tabulated 
illustrating that LB is the best condition.  
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and 4-9b). Based on these results, pAzF incorporation into GFP and thus into HEWL 
can be performed in BL21 DE3 cells and LB media. 
4.8 Expression of pAzF-incorporated HEWL variants 
After establishing initial conditions to test pAzF incorporation, we moved forward 
to test expression of the HEWL variant (Figure 4-10). The protein was produced in BL21 
DE3 cells in LB media while other conditions such as induction temperature were 
optimized for expression of WT and both variants of HEWL. The test expressions were 
analyzed by 15% SDS-PAGE, and band for HEWL was expected around 14.5 kDa 
(Figure 4-10).  There was no visible band for HEWL expression in the supernatant for 
any of the induction temperatures tested (Figure 4-10a). This indicates that HEWL 
expresses in the inclusion bodies. There are bands corresponding to the correct size of 
HEWL over-expression in the pellet (Figure 4-10b). Specifically, the black box in Figure 
4-10b corresponds to successful expression of S99 pAzF HEWL. The other two bands 
15 
10 
25 
35 
55 
MW 
Figure 4-10. Induction temperatures for HEWL variants were investigated. a) 
15% SDS-PAGE gel of the supernatant of WT, S99 pAzF, and F52 pAzF 
HEWL expression. b) 15% SDS-PAGE gel of the pellet of WT, S99 pAzF, and 
F52 pAzF HEWL expression. The black box in lane 12 indicates over-
expression of S99 pAzF HEWL when induced at 37 °C. 
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consistent with HEWL in Figure 4-10b correspond to WT HEWL expressing in the pellet. 
There was no over-expression of the F52 pAzF HEWL variant at any condition tested 
(Figure 4-10). Thus, larger scale expression of S99 pAzF HEWL variant was pursued 
with induction at 37 °C and subsequent purification.  
After expression and induction of the S99 pAzF HEWL variant, the protein was 
further purified with cation exchange chromatography and then size-exclusion 
chromatography (SEC) in denaturing conditions (Figure 4-11). HEWL has an isoelectric 
point (pI) of 9.1, giving it an overall positive charge. Thus, it was purified using strong 
cation exchange chromatography. HEWL can be eluted from the column by changing 
the ionic strength of the buffer (Figure 4-11a). The black box in Figure 4-11a indicates 
the bands corresponding to the correct size of the HEWL variant. For further purification 
 
Figure 4-11. Purification of S99 pAzF HEWL. a) A 15% SDS-PAGE gel of S99 
pAzF HEWL purification with cation exchange chromatography. Lane numbers 
indicate 1) PageRuler Plus prestained protein ladder (Thermo Scientific), 2-13) 
washes with increasing salt concentration to elute protein. S99 pAzF HEWL 
eluted around 100 – 200 mM NaCl as highlighted by the black box. b) 15% 
SDS-PAGE gel of S99 pAzF HEWL purification with size-exclusion 
chromatography. Lane numbers indicate 1) PageRuler Plus prestained protein 
ladder (Thermo Scientific), 2) protein sample before SEC, 3) protein sample 
after SEC.  
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before refolding, the HEWL variant was purified with SEC. The HEWL variant was 
purified to ~90% homogeneity as depicted in the SEC results analyzed by 15% SDS-
PAGE (Figure 4-11b). After purification, the HEWL variant was refolded by rapid 
dilution44 and the secondary structure was measured by Circular Dichroism (CD). Figure 
4-12 depicts the CD spectrum of refolded HEWL ,which is very similar to published 
reports.45 After refolding, the yield of HEWL was decreased by 75%; these yields were 
insufficient for further experiments.  
  
Figure 4-12. CD spectrum of refolded S99 pAzF 
HEWL 
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4.9 Expression of soluble S99 pAzF HEWL variant 
 Due to issues deriving from HEWL refolding, new methods were pursued to 
express HEWL as a soluble construct without the added step of refolding. Previous 
work by Schultz et al indicated that cloning a protein into a pBAD plasmid with an 
araBAD promoter could help with protein solubility.46,47 Furthermore, Schultz et al 
developed a new vector system (pULTRA) for aaRS/tRNA pair to allow better 
incorporation of the UAA.47 Therefore, we cloned S99 pAzF HEWL variant into a pBAD 
vector and pAzF aaRS/tRNA pair into a pULTRA vector. The S99 pAzF HEWL variant 
(size around 13 
kDa) was 
successfully 
overexpressed in 
BL21 DE3 cells 
in its soluble 
form, and 
purified by nickel 
affinity 
chromatography, 
then SEC. The 
protein is 
visualized by 
15% SDS-PAGE 
and a black box 
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Figure 4-13. S99 pAzF HEWL activity and reactivity assays. a) 
Lysozyme fluorescent-based activity assay results demonstrate 
fluorescence only in the presence of protein. b) 15% SDS-PAGE 
of S99 pAzF HEWL. Lane numbers indicate 1) PageRuler Plus 
prestained protein ladder (Thermo Scientific), 2) S99 pAzF 
HEWL reacted with AlexaFluor488 alkyne but with no Cu (1) 
catalyst, 3) S99 pAzF HEWL reacted with AlexaFluor 488 alkyne 
with Cu (1) catalyst. The reaction was run for 1 h. c) Same 15% 
SDS-PAGE from b, however a fluorescence image was 
visualized with the blue/green filter by the Typhoon.  
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labels the band consistent with the expected size of HEWL (Figure 4-13b).  
With S99 pAzF HEWL in hand, its activity was assayed and compared to WT 
HEWL (Figure 4-13a).  S99 pAzF HEWL retains lysozyme activity as assayed by a 
commercially available fluorescent activity assay (EnzChek Lysozyme Assay Kit, 
Thermo Fisher Scientific). In this assay, as lysozyme degrades peptidoglycan with an 
incorporated fluorophore, the fluorophore is released thus increasing fluorescence 
detected by a fluorescent plate reader. As shown in Figure 4-13a, both samples with 
HEWL show greatly increased fluorescence values compared to a negative control with 
no enzyme present to degrade the fluorogenic substrate.  The S99 pAzF HEWL variant 
shows similar activity to WT HEWL. The results demonstrate that the S99 pAzF HEWL 
is active, and the incorporated azide functionality does not significantly interfere with 
activity.  
Next, the reactivity of the azide functionality was tested in a CuAAC click 
reaction. S99 pAzF HEWL was reacted with an AlexaFluor488 alkyne for one hour. The 
CuAAC click reaction was applied using 2 equivalents of click ligand 1 (structure shown 
in Figure 4-4), which showed increased solubility in water. Two samples were prepared, 
one with Cu(1) catalyst and one without. The CuAAC reaction was resolved by SDS-
PAGE, and visualized by UV transillumination (fluorescence) before Coomassie staining 
of the protein bands. Reactivity was detected by fluorescence under the LBP (510LP) 
filter in the Typhoon scanner (Figure 4-13c). The successful reaction was confirmed by 
the robust fluorescence associated with the protein bands, as depicted by the black box 
in Figure 4-13c. Only the S99 pAzF HEWL sample with a Cu(1) catalyst present showed 
fluorescence on the gel. There is some dimer formation of the HEWL variant as 
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visualized by the higher band on the gel. Overall, these results indicate that S99 pAzF 
HEWL is refolded, active and reactive with an alkyne.  
4.10 Bioconjugation of S99 pAzF HEWL to SWCNT 
The goal of this project was to develop a new and effective bioconjugation 
method to attach proteins to SWCNTs. Thus, the S99 pAzF HEWL variant was tested 
for successful 
attachment to 
SWCNT using an 
anthracenyl alkyne 
(figure 4-14). As 
discussed 
previously 
(Chapter 3), 
anthracene 
demonstrates 
better overall 
solubility than 
pyrene and slightly 
better attachment 
results. The S99 
pAzF HEWL was 
clicked to 
anthracene alkyne 
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as depicted in Figure 4-14a. The reaction was left overnight at room temperature in the 
dark. After dialysis to remove excess reagents, attachment to SWCNT was tested. The 
solution was applied to a nanodevice for 1 h. After incubation, the SWCNT was imaged 
by AFM and analyzed for particles consistent with the size of HEWL (Figure 4-14b). 
This AFM image depicts three possible protein attachments to the SWCNT. These 
results indicate better attachment yields than the current methods (Chapter 2 and 3), 
and further studies are in progress to confirm this preliminary data. In summary, UAA 
incorporation of pAzF into HEWL and subsequent attachment to SWCNT is a superior 
method for bioconjugation to carbon nanotubes.  
4.11 Conclusions: 
In conclusion, we have investigated an alternative bioconjugation strategy to 
thiol-maleimide chemistry for attachment to SWCNT-FET devices. This approach 
utilizes UAA incorporation of an azide side chain for reactivity in the CuAAC click 
reaction. The pAzF was first tested in a GFP model system, and then HEWL. A variant 
of HEWL was developed to incorporate the pAzF at the S99 position. Further 
optimization of conditions for HEWL expression and efficient UAA incorporation was 
pursued. The HEWL variant was active and the azide functionality was available for 
reaction with a fluorescent alkyne molecule. These initial experiments demonstrate the 
ability to use UAA incorporation for potential use in bioconjugation to SWCNT. 
Furthermore, this bioconjugation strategy expands the utility of SWCNT-FETs to many 
other proteins, previously inaccessible by the current attachment method. As mentioned 
earlier, there has been some work attaching proteins to SWCNT using UAAs,27 
however, no work has been done up until now to noncovalently functionalize SWCNT 
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with UAA incorporation. Thus, this technique can be expanded to include other 
bioorthogonal functionalities to develop other bioconjugation strategies for SWCNT 
devices.  
4.12 Materials and Methods:  
Materials 
Reagents purchased commercially include antibiotics (Fisher Scientific), cation 
exchange resin (Bio-Rad Laboratories), cell lines (Stratagene), DNA purification kits 
(Invitrogen, Qiagen or Zymo Research), deoxyribonucleotides (Promega Corporation), 
enzymes (New England Biolabs or Fermentas), oligonucleotides (IDT), and 96-well 
plates (Nunc). Other chemicals were purchased commercially from Acros Organics, 
EMD, Fisher Scientific, or Sigma Aldrich. Unless otherwise indicated below, reagents 
were used as received. 
Expression of HEWL 
A typical purification scheme included the following steps. After overexpression, 
cells were harvested by centrifugation (6000 g, 20 min, 4 °C) and resuspended in lysis 
buffer (20 mM Tris, 10 mM NaCl, pH 7.5). Cells were lysed by sonication (10 s pulses at 
40% power with 1 min rest in between for a total of 10 cycles) and centrifuged (15,000 
g, 45 min, 4 °C) to remove cell debris. After centrifugation, the supernatant was 
discarded, and the cell pellet was resuspended in resuspension buffer (8 M urea, 20 
mM Tris-HCl, 20 mM NaCl, pH 7.2) overnight. Then the resuspended cell pellet was 
centrifuged (15,000 g, 2 h, 4 °C) to remove cell debris. After centrifugation, the 
supernatant was filtered (0.45 μm and then 0.22 μm pore size) prior to FPLC (Bio-Rad 
Biologic DuoFlow FPLC) using cation exchange chromatography. The protein was 
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eluted with a gradient of 1 M NaCl in 8 M urea. Fractions containing the protein were 
concentrated before filtration with a 0.45 μm and 0.22 μm filter. Further purification 
applied size exclusion chromatography in 8 M urea in PBS (140 mM NaCl, 2.7 mM KCl, 
8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2). The purity of WT and S99 pAzF HEWL 
were assessed by SDS-PAGE. Fractions containing pure protein were collected and 
concentrated to 2 mg/ml using 3 kDa MWCO concentrators. Refold HEWL by rapid 20-
fold dilution into buffer containing 50 mM Tris-HCl, 50 mM KCl, 1 mM EDTA, 5 mM 
reduced glutathione, and 0.5 mM oxidized glutathione. After dilution, the protein was 
dialyzed twice for 12 h in PBS (pH 7.2). For the soluble HEWL variant, after 
overexpression, cells were harvested by centrifugation (6000 g, 20 min, 4 °C) and 
resuspended in lysis buffer (20 mM Tris, 10 mM NaCl, pH 7.5). Cells were lysed by 
sonication (10 s pulses at 40% power with 1 min rest in between for a total of 10 cycles) 
and centrifuged (15,000 g, 45 min, 4 °C) to remove cell debris. After centrifugation, the 
supernatant was filtered (0.45 μm and then 0.22 μm pore size) prior to FPLC (Bio-Rad 
Biologic DuoFlow FPLC) using Nickel-charged IMAC resin. The protein was next eluted 
with a gradient of 250 mM imidazole. Fractions containing the protein were 
concentrated before filtration with a 0.45 μm and 0.22 μm filter. Further purification 
applied size exclusion chromatography in PBS. The purity of S99 pAzF HEWL was 
assessed by SDS-PAGE. 
Mutagenesis of HEWL into pBAD vector and pAzF aaRS/tRNA pair into pULTRA vector 
A pBAD bacterial expression vector containing the gene encoding GFP was cut 
out using the restriction sites (NcoI and BamHI). The DNA sequence encoding the 
HEWL variant was engineered with PCR to contain the same restriction sites using the 
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following oligonucleotides. Furthermore, a pULTRA bacterial expression vector 
containing the gene encoding PyrrolLysyl aaRS/tRNA pair was digested using the 
restriction sites (NdeI and NcoI). The pAzF aaRS/tRNA pair was engineered with the 
same restriction sites using the following oligonucleotides.  
Oligonucleotides: 
HEWL_pBAD_FWD_FINAL: 5‟ - AGA TAC GAA TTC CTC GAG CCA TGG CAT ATG 
GGC GGT ATG AAA GTT TTT GGC CGT TGC – 3‟  
HEWL_pBAD_NewREV: 5'- AAG CTT TCT AGA GTC GAC GGA TCC ACT AGT TCA 
GTG ATG ATG ATG ATG ATG GCC GCT TTG AAA ATA AAG ATT TTC CAA ACG 
GCA ACC -3'  
pAzF_pULTRA _FWD_FINAL: 5‟ - TGG ACG CGG CCG AAG CTT CAT ATG GCG 
GCC GCA GGT GGC ATG GAC GAA TTT GAA ATG ATA AAG AGA AAC – 3‟  
pAzF_pULTRA_REV_FINAL: 5'- GGA ATC GGT ACC ACT AGT CCA TGG CTC GAG 
ACC GCC TTA TCA TTA AGC GCA TTG GAT GCA ATT -3' 
Circular dichroism of HEWL variant 
The circular dichroism spectra of the S99 pAzF HEWL variant (15 μM) was 
acquired using a spectropolarimeter (JASCO model J-810) at 22 °C with the following 
parameters: 1.0 nm bandwidth, 0.1 cm path length, 2.0 s response time, and 10 nm/min 
scanning speed. Spectra were recorded as the average of three acquisitions and 
corrected by subtraction of the equivalent measurements for the buffer. 
Activity of HEWL variants 
The activity of WT and S99 pAzF HEWL in PBS (5 μM) was measured using the 
EnzChek® Lysozyme Assay Kit (Invitrogen).  
106 
 
CuAAC click reaction  
 The CuAAC click reaction was performed following a previously reported 
protocol.14 The reaction components, other than alkyne and azide, typically include 
CuSO4, a reducing agent (e.g., ascorbic acid), and a ligand to stabilize the in situ-
generated Cu(I) species. The reaction was incubated at 23 °C in the dark for an hour or 
overnight.  
Attachment to SWCNT 
After the HEWL variant was reacted with the anthracene alkyne, the reaction 
mixture was sterile-filtered with a 0.22 µm syringe filter and then dialyzed overnight into 
PBS with 300 mM NaCl. Then, the protein solution was applied to SWCNT device for 
one hour and rinsed with deionized water before imaging by AFM.  
4.13 References:  
1. Sletten, E. M.; Bertozzi, C. R. Angew. Chem., Int. Ed. 2009, 48, (38), 6974-6998. 
2. Hermanson, G. T., Chapter 22 - Enzyme Modification and Conjugation. In 
Bioconjugate Techniques (Third edition), Academic Press: Boston, 2013; pp 951-957. 
3. Dibowski, H.; Schmidtchen, F. P. Angew. Chem., Int. Ed. 1998, 37, (4), 476-478. 
4. Dirksen, A.; Dawson, P. E. Bioconjugate Chem. 2008, 19, (12), 2543-2548. 
5. Lampkowski, J. S.; Villa, J. K.; Young, T. S.; Young, D. D. Angew. Chem., Int. 
Ed. 2015, 54, (32), 9343-9346. 
6. Li, N.; Lim, R. K. V.; Edwardraja, S.; Lin, Q. J. Am. Chem. Soc. 2011, 133, (39), 
15316-15319. 
7. Maza, J. C.; McKenna, J. R.; Raliski, B. K.; Freedman, M. T.; Young, D. D. 
Bioconjugate Chem. 2015, 26, (9), 1884-1889. 
8. Reddington, S.; Watson, P.; Rizkallah, P.; Tippmann, E.; Jones, D. D. Biochem. 
Soc. Trans. 2013, 41, (5), 1177-1182. 
9. Kolb, H. C.; Sharpless, K. B. Drug Discovery Today 2003, 8, (24), 1128-1137. 
10. Baskin, J. M.; Bertozzi, C. R. QSAR Comb. Sci. 2007, 26, (11-12), 1211-1219. 
11. Chen, Y.-X.; Triola, G.; Waldmann, H. Acc. Chem. Res. 2011, 44, (9), 762-773. 
12. Hoyle, C. E.; Bowman, C. N. Angew. Chem., Int. Ed. 2010, 49, (9), 1540-1573. 
13. Hein, J. E.; Fokin, V. V. Chem. Soc. Rev. 2010, 39, (4), 1302-1315. 
14. Lutz, J.-F. Angew. Chem., Int. Ed. 2007, 46, (7), 1018-1025. 
15. Chakraborty, A.; Mazumder, A.; Lin, M.; Hasemeyer, A.; Xu, Q.; Wang, D.; 
Ebright, Y. W.; Ebright, R. H. Methods Mol. Biol. 2015, 1276, (Bacterial Transcriptional 
Control), 101-131. 
107 
 
16. Hermanson, G. T., Chapter 17 - Chemoselective Ligation; Bioorthogonal 
Reagents. In Bioconjugate Techniques (Third edition), Academic Press: Boston, 2013; 
pp 757-785. 
17. Steen Redeker, E.; Ta, D. T.; Cortens, D.; Billen, B.; Guedens, W.; Adriaensens, 
P. Bioconjugate Chem. 2013, 24, (11), 1761-1777. 
18. Kalia, J.; Raines, R. T. Angew. Chem., Int. Ed. 2008, 47, (39), 7523-7526. 
19. Wendeler, M.; Grinberg, L.; Wang, X.; Dawson, P. E.; Baca, M. Bioconjugate 
Chem. 2014, 25, (1), 93-101. 
20. Young, T. S.; Schultz, P. G. J. Biol. Chem. 2010, 285, (15), 11039-11044. 
21. Liu, C. C.; Schultz, P. G. Annu. Rev. Biochem. 2010, 79, 413-444. 
22. Bain, J. D.; Diala, E. S.; Glabe, C. G.; Dix, T. A.; Chamberlin, A. R. J. Am. Chem. 
Soc. 1989, 111, (20), 8013-14. 
23. Davis, L.; Chin, J. W. Nat. Rev. Mol. Cell Biol. 2012, 13, (3), 168-182. 
24. Mendel, D.; Cornish, V. W.; Schultz, P. G. Annu. Rev. Biophys. Biomol. Struct. 
1995, 24, 435-462. 
25. Wang, L.; Xie, J.; Schultz, P. G. Annu. Rev. Biophys. Biomol. Struct. 2006, 35, 
225-249. 
26. Ikeda-Boku, A.; Kondo, K.; Ohno, S.; Yoshida, E.; Yokogawa, T.; Hayashi, N.; 
Nishikawa, K. J. Biochem. 2013, 154, (2), 159-165. 
27. Yoshimura, S. H.; Khan, S.; Ohno, S.; Yokogawa, T.; Nishikawa, K.; Hosoya, T.; 
Maruyama, H.; Nakayama, Y.; Takeyasu, K. Bioconjugate Chem. 2012, 23, (7), 1488-
1493. 
28. Hutchins, B. M.; Kazane, S. A.; Staflin, K.; Forsyth, J. S.; Felding-Habermann, B.; 
Smider, V. V.; Schultz, P. G. Chem. Biol. (Cambridge, MA, U. S.) 2011, 18, (3), 299-
303. 
29. Fomenko, D. E.; Xing, W.; Adair, B. M.; Thomas, D. J.; Gladyshev, V. N. Science 
2007, 315, (5810), 387-389. 
30. Giles, N. M.; Giles, G. I.; Jacob, C. Biochem. Biophys. Res. Commun. 2002, 300, 
(1), 1-4. 
31. Zechel, D. L.; Withers, S. G. Acc. Chem. Res. 2000, 33, (1), 11-18. 
32. Heckler, T. G.; Chang, L. H.; Zama, Y.; Naka, T.; Chorghade, M. S.; Hecht, S. M. 
Biochemistry 1984, 23, (7), 1468-1473. 
33. Anthony-Cahill, S. J.; Griffith, M. C.; Noren, C. J.; Suich, D. J.; Schultz, P. G. 
Trends Biochem. Sci. 1989, 14, (10), 400-403. 
34. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. 
Ed. 2002, 41, (14), 2596-2599. 
35. Tornoe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, (9), 3057-
3064. 
36. Hong, V.; Presolski, S. I.; Ma, C.; Finn, M. G. Angew. Chem., Int. Ed. 2009, 48, 
(52), 9879-9883, S9879/1-S9879/10. 
37. Hein, J. E.; Tripp, J. C.; Krasnova, L. B.; Sharpless, K. B.; Fokin, V. V. Angew. 
Chem., Int. Ed. 2009, 48, (43), 8018-8021, S8018/1-S8018/64. 
38. Chan, T. R.; Hilgraf, R.; Sharpless, K. B.; Fokin, V. V. Org. Lett. 2004, 6, (17), 
2853-2855. 
39. Lee, B. S.; Shin, S.; Jeon, J. Y.; Jang, K.-S.; Lee, B. Y.; Choi, S.; Yoo, T. H. ACS 
Chem. Biol. 2015, 10, (7), 1648-1653. 
108 
 
40. Chin, J. W.; Santoro, S. W.; Martin, A. B.; King, D. S.; Wang, L.; Schultz, P. G. J. 
Am. Chem. Soc. 2002, 124, (31), 9026-9027. 
41. Boujtita, M., Chemical and biological sensing with carbon nanotubes (CNTs). In 
Nanosensors for Chemical and Biological Applications, Honeychurch, K. C., Ed. 
Woodhead Publishing: 2014; pp 3-27. 
42. Wang, A.; Nairn, N. W.; Marelli, M.; Grabstein, K. In Protein engineering with 
non-natural amino acids, 2012; InTech: pp 253-290. 
43. Lajoie, M. J.; Kosuri, S.; Mosberg, J. A.; Gregg, C. J.; Zhang, D.; Church, G. M. 
Science 2013, 342, (6156), 361-363. 
44. Schlörb, C.; Ackermann, K.; Richter, C.; Wirmer, J.; Schwalbe, H. J. Biomol. 
NMR 2005, 33, (2), 95-104. 
45. Esquembre, R.; Sanz, J. M.; Wall, J. G.; del Monte, F.; Mateo, C. R.; Ferrer, M. 
L. Phys. Chem. Chem. Phys. 2013, 15, (27), 11248-11256. 
46. Ravikumar, Y.; Nadarajan, S. P.; Yoo, T. H.; Lee, C.-S.; Yun, H. Biotechnol. J. 
2015, 10, (12), 1862-1876. 
47. Chatterjee, A.; Sun, S. B.; Furman, J. L.; Xiao, H.; Schultz, P. G. Biochemistry 
2013, 52, (10), 1828-1837. 
 
109 
 
Chapter 5: Conclusion 
5.1 Conclusions 
Biological function is ultimately rooted in the physical motions of biomolecules. 
Many biological processes are controlled by alterations in rates and relative populations 
rather than by a simple ‘on–off’ switch. For example, enzymes speed up chemical 
reactions, and changes in intracellular ion concentrations trigger complex neurological 
processes. Considering the immense rate enhancements and equilibrium shifts that are 
achieved by enzymes, it is easy to overlook the fact that only small changes in free 
energy (around a few kT) account for these effects.1 In other words, the breaking of a 
few hydrogen bonds or van der Waals contacts in a protein, which contains hundreds to 
thousands of such interactions, can activate a signaling cascade or catalyze a chemical 
reaction. Importantly, intrinsic protein dynamics can happen only in this free-energy 
range of several kT. However, the tools to study such enzyme dynamics are limited.  
The intersection of nanotechnology and biology has produced biophysical 
methods that can record protein behavior as it undergoes minor conformational 
changes. For example, the development of SWCNT-FETs by the Weiss and Collins 
collaboration has allowed for real time measurements at the single molecule level on 
the microsecond timescale. Previously, T4 lysozyme-functionalized SWCNT-FET 
devices revealed information about the detailed mechanism through which lysozyme 
degrades bacterial cells. This technology couples enzymatic motion with an electronic 
readout. Using this technique can uncover exciting new information about an enzyme 
that has been studied for over a century. We have shown that this method serves as a 
general single-molecule technique as we have monitored the kinetics and dynamics of 
enzymes that form ternary complexes such as KF and PKA.2,3 
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We developed a single cysteine variant of PKA to attach to the SWCNT-FETs 
(Chapter 2). Electronic measurements of PKA in the presence of either ATP or 
Kemptide alone induced two-level switching. The mean duration of PKA bound to ATP 
was 3.1 ms and for PKA-Kemptide the time was 1.8 ms. This suggested that PKA 
needs more time to bind to ATP. Three-level current fluctuations were induced only 
when both substrate and co-factor for PKA were present. Further analysis indicated that 
the single molecule data of PKA corroborates ensemble measurements.3 The majority 
of PKA catalytic turnovers (77%) followed a sequence of open-intermediate-closed-
open conformations with an effective rate of 155 s-1. While in the other 23% of catalytic 
turnovers, PKA fluctuates between intermediate and closed conformations multiple 
times before finally opening again. This indicates that PKA fluctuates 23% of the time to 
find the correct conformation to undergo catalysis. PKA is a very dynamic protein 
compared to lysozyme or KF, revealing catalytic rates varying two orders of magnitude 
from one second to the next. The wide range of processing rates for PKA may allow 
accessory proteins to regulate its activity in cells.3 
To expand this technique to other biological systems, we systematically 
investigated many variables involved in the bioconjugation mechanism for these 
enzyme-functionalized devices (Chapter 3). For example, to improve the thiol-maleimide 
reaction we synthesized novel linker molecules, such as anthracene maleimide with 
improved solubility in ethanol. The increased solubility of anthracene maleimide 
increased protein attachment yields to SWCNTs three-fold. Moreover, we developed 
possible solutions to overcome challenges inherent to the thiol-maleimide chemistry, 
such as TCEP interference. The concise synthesis of the dimethylmaleimide derivative 
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allowed for study of this molecule in bioconjugation. While preliminary results indicate 
improved attachment yields with dimethylmaleimide in the presence of TCEP, further 
studies will be needed to confirm this.  
Other variables we investigated for bioconjugation were buffer composition and 
protein characteristics that address the bottleneck in nanocircuit device fabrication. The 
thiol-maleimide chemistry faces issues of maleimide hydrolysis in alkaline conditions 
and Tris buffers, thus limiting concentrations of maleimide available for the reaction. 
Additionally, removing protein aggregates and ensuring >99% protein homogeneity 
played key roles in preventing nanocircuit surface fouling. Adding detergent to the wash 
steps allowed for further decrease in surface biofouling while preventing non-specific 
adsorption of particles onto the surface.  
To overcome the challenges inherent to thiol-maleimide chemistry, a 
bioconjugation strategy employing unnatural amino acid incorporation of azide 
functionality was explored. A variant of HEWL was engineered that incorporated a pAzF 
into the S99 position. We optimized expression and purification conditions for S99 pAzF 
HEWL that retained enzymatic activity. In addition, the azide functionality incorporated 
in HEWL was reactive in the CuAAC click reaction with alkyne linker molecule for 
SWCNT (Chapter 4). Initial data suggests that this bioconjugation method using S99 
pAzF HEWL is a better strategy for tethering biomolecules to the SWCNT than thiol-
maleimide chemistry. These preliminary results open the door to many other proteins 
previously inaccessible to this nanotechnology.   
Overall, SWCNT transistors allow for long duration monitoring of single enzyme 
dynamics. Throughout this dissertation, I have applied this technology to a new protein, 
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PKA, as well as delved into the mechanistic details of the bioconjugation strategy. I 
developed a new method for bioconjugation that allows the application of this project to 
numerous proteins. Moving forward, having established a reliable attachment protocol, 
measurements with novel proteins will provide insights into single-molecule protein 
dynamics. Future experiments can further research the application of the new 
bioconjugation method to SWCNT-FETs for huge amount of proteins that we previously 
could not study using thiol-maleimide chemistry. Now these single-molecule 
nanocircuits can be used to study essentially any enzyme in action. These nanocircuits 
will allow for the deeper understanding of how individual enzyme molecules operate at 
the most detailed level. 
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